Podcasts about dkk

Brent råolieSaudi Arabien sætter pres på snyderne i OPEC+ og fremrykker et højere produktionsniveau i OPEC+. Dette vil sandsynligvis også ske på næste OPEC+ møde den 1. juni 2025. I kombination med en handelskrig er sandsynligheden nu forhøjet for lavere oliepriser. Vi sænker prognosen for Brent med $5, og vi venter Brent nær $60 gennem sommeren og $57 mod 1. kvartal 2026.DieselEn ny verdensorden med ekstrem økonomisk og finansiel usikkerhed betyder, at fokus bør centrere sig om at beskytte virksomhedens kerneforretning. Opportunisme må vente i vores øjne. Terminskurven er flad, og trods vores forventning om en lavere dieselpris anbefaler vi at holde en normal prissikring af 2025-forbruget samt at indlede prissikringen af 2026 til nær DKK 3,30.NaturgasNy hård retorik mod Rusland i aftalen mellem Ukraine-USA kan påvirke EU's plan for udfasning af bl.a. russisk gas, som kommer i morgen, tirsdag. Salgspresset på den europæiske gaspris dominerer dog stadig, og vi venter en succesfuld genopfyldning af Europas gaslagre mod næste vinter. Vi forventer en gaspris omkring €35 mod næste vinter og anbefaler en normal prissikring af gasforbruget.Læs hele analysen her.Vigtig investorinformation.

Brent råolieEfterspørgselsrisici – makro såvel som olie – er i vores øjne centreret omkring nedsiden. Udsigten for olieudbuddet er mere tosidig i lyset af presset på Iran og Venezuela, mens snyd hos OPEC+ bør holde produktionsvækst tilbage indtil august. Brent har stabiliseret sig, men netto forventer vi et olieoverskud, en Brent omkring $65 gennem sommeren og derefter vigende mod $62 i 1. kvartal 2026.DieselDen amerikanske administrations daglige luner ændrer ikke på, at vi står konfronteret med ekstrem økonomisk og finansiel usikkerhed. Fokusér på at beskytte virksomhedens kerneforretning og prissikre normalen af dieselforbruget for hele 2025 (typisk 50%). Er prissikring endnu længere ud i tiden tilladt, så kan vi også anbefale at påbegynde en trinvis prissikring af forbruget i 2026 til nær DKK 3,35.NaturgasDet skotter ikke på risici i tiden, og derfor er det glædeligt, at de europæiske gasforbrugere har udsigt til en succesfuld genopfyldning af Europas gaslagre før næste vinter. En situation som mindsker priskonkurrencen med Asien, og vi venter en gaspris nær €35. Den flade terminskurve kan dermed blive realiseret. Fasthold en normal prissikring af gasforbruget til og med næste vinter.Læs hele analysen her.Vigtig investorinformation.

Brent råolieDonald Trumps told-pause stabiliserer situationen her og nu, men sandsynlighed er blevet større for, at både efterspørgslen viger og olielagrene stiger mere end hidtil ventet. Mens fundamentalerne udspiller sig langsomt, så kan de finansielle priser afgive væsentligt fra denne virkelighed, som oplevet i sidste uge. Vi sænker prognosen for Brent med $3 til $65 gennem sommeren og $62 i 1. kvartal 2026. DieselEkstreme prisudsving i takt med stor usikkerhed omkring både efterspørgsel og olieudbuddet. Fasthold fokus på at beskytte virksomhedens kerneforretning. Vi anbefaler en normal afdækningsgrad af dieselforbruget for hele 2025. Er prissikring endnu længere ude i tiden tilladt, så ser vi det attraktivt at påbegynde en trinvis prissikring af forbruget gennem 2026 til nær DKK 3,35. NaturgasDer er gode nyheder til de europæiske gasforbrugere. En ny LNG-eksportterminal i USA har stor succes, hvilket sammen med et globalt pres på efterspørgslen, ændrer behovet for en højere europæisk gaspris over sommeren. Vi kan dermed sænke prognosen til €35 (€45), og terminskurven kan dermed blive realiseret. Fasthold en normal risikoafdækning af gasforbruget til og med næste vinter.Læs hele analysen her.Vigtig investorinformation.

DNA and RNA sequence analysis enable researchers to form a total overview of which species of microorganisms and parasites live with humans, animals and plants. It is not just in our gut where microorganisms are playing a role in our digestion. Also on the skin and all mucous membranes, in the mouth and all the way down into the hair follicles, we live together with parasites and microorganisms which help to shape our lives and our development. This knowledge makes it possible to see organisms in a far more holistic perspective, which provides a far better understanding of the factors that have evolutionarily shaped the species as they now appear in nature. In this podcast, Science Journalist Jens Degett talks to Professor Marcus Thomas Pius Gilbert from the Center for Evolutionary Hologenomics (CEH) at the University of Copenhagen. The center has recently received DKK 67.7 million from the Danish National Research Foundation. Photo credit: Jens Degett

I denne uges episode ser vi nærmere på ugens aktie-smackdown og de vigtigste takeaways derfra - og kigger på historikken på denne slags korrektioner på aktiemarkedet. Vi har besøg af investeringsstrateg Lars Skovgaard fra Danske Bank, der deler sine perspektiver på markedet. Ugens tema byder på en debat om ‘europæisk tech' – købsmulighed? Hvor står vi, og hvad bringer fremtiden? Derudover gennemgår vi en række spændende regnskaber og meget mere! Denne episode er sponsoreret af MBA på CBS. På CBS kan du tage efteruddannelsesprogrammer på 2 år. Læs mere på efteruddannelse.cbs.dk/mba. Denne episode er sponsoreret af NewDeal Invests PMINDI - nu en akkumulerende version og VSO-venlig. Der er indtil videre en minimumsinvestering på 750k DKK. Find den på Fundmarket.dk.Læs mere på ⁠Newdealinvest.dk⁠.NewDeal Invests nyhedsbrev: Newdealinvest.dk/nyhedsbrev/ Denne episode er sponsoreret af Finobo. Få et gratis økonomitjek hos specialisterne i låneoptimering ved at bruge linket:finobo.dk/gratis-oekonomitjek-aktieuniverset/Prøv den nye omlægningsberegner på Finobo.dk/beregner-omlaegningsberegner/?utm_source=aktieuniverset Tjek os ud på:FB gruppe: ⁠facebook.com/groups/1023197861808843⁠X: ⁠x.com/aktieuniverset⁠IG: ⁠instagram.com/aktieuniversetpodcast⁠

Efter 2 års intervalhandel for USD sender Donald Trump amerikanske aktiver og valutaen højere og udfordrer derigennem manges negative fortolkninger af Trumps forventede politik. Vi opjusterer USD til EUR 0,97 (DKK 7,70) i 1. kvartal for derefter at slutte året en smule mindre stærk. • USD-efterspørgsel overrasker konsensus og kapitalforvaltere • Global vækst og færre rentenedsættelser • Risikoscenarie: Konsekvenser af Trump-politik ikke givne   Læs hele analysen her. Vigtig investorinformation.

Med Trump ved roret i USA fra januar foretager vi en gennemgående revidering af vores hoved- og risikoscenarie. Trumps forventede politik vil være fokuseret på at styrke USA's økonomi, mens Trump tilfører den øvrige verden risici. Vi forventer nu en stigende USD mod EUR 1,0450 og DKK 7,14. En velkendt og velforberedt Donald Trump med fuldt flertal Pengepolitiske rentesænkninger: færre hos Fed, men ECB fremrykket Risikoscenarie: Konsekvenser af Trump-politik ikke givne Læs hele analysen her.

Salgspresset på USD er igen blevet afvist nær EUR 1,12, og vi venter, at USD stabiliserer sig nær EUR 1,085 (DKK 6,88) i optakten til præsidentvalg og en afklaring på Israels ventede modangreb. I 2025 bliver USD igen sat under pres af en blød økonomisk landing og potentielt en status quo i Mellemøsten. Læs hele analysen her. Vigtig investorinformation.

Dagens episode er med Kristoffer Degn, der tilbage i 2020 var med til at stifte det nu konkursramte B2B SaaS selskab, Custimy. Der har været fart på med store investeringsrunder, mange ansatte og højt cash burn. Noget gik godt men konkursen fortæller naturligvis også at meget gik skidt. Hør Kristoffers ærlige fortælling med refleksioner på bagkant af konkursen. Husk endelig at gøre brug af rabatkoden "FREMTIDSFABRIKKEN", der giver alle førstegangsbrugere af GoMore 150 DKK til brug på plaftformen. Lease, udlej eller lej jeres bil på gomore.dk - det kører bare! Link til FAQ omkring beskatning på Gomore.dk Connect med os på LinkedIn: https://www.linkedin.com/in/larshorsbol/  https://www.linkedin.com/in/eskegerup/ 

Dagens episode er med vores gode kammerat, favorit-jurist og genganger, Gustav Thybo, som for nyligt har haft 10-års jubilæum i Flyhjælp og stopper på toppen, TILLYKKE! Derfor skal vi selvfølgelig høre om Flyhjælps genfødsel efter corona, salget af Flyhjælp til Flightright, Gustavs oplevelse af at sælge til en tysk-ejet koncen og de kommende planer i Flyhjælp.  Husk endelig at gøre brug af rabatkoden "FREMTIDSFABRIKKEN", der giver alle førstegangsbrugere af GoMore 150 DKK til brug på plaftformen. Lease, udlej eller lej jeres bil på gomore.dk - det kører bare! Link til FAQ omkring beskatning på Gomore.dk Connect med os på LinkedIn: https://www.linkedin.com/in/larshorsbol/  https://www.linkedin.com/in/eskegerup/ 

Brent råolieMed Brent i godt $85 er forholdet mellem risiko og gevinst næppe længere attraktiv for hverken nye spekulanter eller forbrugere. Efterspørgselsuro i løbet af sommeren f.eks. omkring Kina kan kortvarigt sende Brent tilbage mod $80 – og her bliver det igen attraktiv for købere i forventningen om, at oliebalancen udviser underskud mod efteråret fulgt af en stigning mod $90… før lavere ind i 2025.DieselEr risikoafdækningen af 3. kvartalsforbruget ikke indgået, så ser vi det attraktiv under et potentielt tilbagefald i Brent mod $80-niveauet. Lige nu er risiko og gevinstforholdet ikke interessant. Vi venter stigende dieselpriser mod efteråret, hvor vi sigter mod niveauet DKK 4,95 per liter. For 2025  anbefaler vi en lav risikoafdækning, da en 1 års termin stort set svarer til vores prognoseforventning.NaturgasEU's sanktion mod omladning af russisk LNG øger den opfattede risiko for tab af Europas resterende import af russisk gas denne vinter. Vi ser det attraktivt at afdække et resterende vinterforbrug nær bunden af seneste interval ved €33 før, markedet forventeligt stiger mod €50 i en risikopræmie for evt. mistet russisk gas og for at kunne udkonkurrere Asiens import af amerikansk LNG. LÆS MEREVigtig investorinformation.

DKK - https://soundcloud.com/darlkentkarl SENSES - https://soundcloud.com/senses-dnb Subdulgence Track List: DKK SB81 – Keep Jumpin' Kursa & Ben Pest – Totally Kippered No Remorse – Powerful Mind 11th Hour – Wreckognize BLOCKLAB – Nemanja BLOCKLAB – Street Choice FEARFUL – Contact Forbidden Society – 0606 Subculture – Here We Go FEARFUL & Mtwn – Stalker D:Form – Danger MYTHM – Grim TRUTH – Summer Daze James Blake – Limit To Your Love (11th Hour Remix) Paige Julia – Tōuarangi Dreadmaul – Strange Things De Cet – Come With Music Soul Intent, Dreadmaul – The Sting Trakker – Cold Sweats Detboi – Apnoea Sustance, Sparkz – Take The Risk Molecular – Retro Funk Objectiv – The Goonz (Ft. Untrue) Molecular – Strictly Dub Breaqk – All You Gotta Do Molecular – Soundclash Zero T, L-Side, MC GQ – Raise It Up Amoss – And We Go En:vy – Banned Forbidden Society – Hollow Amoss & Revan – Special Ingredient Xsetra – The Boom Damit Monument Banks – Tranquillity SENSES Prayer For Leaders - Wreckless Type O Negative (Original Mix) - Boycot 7 x 7 (Original Mix) - Ulterior Motive Strapped (Original Mix) - RMS Sl8r Texture (original Mix) - Grintax Submersible - G I I D U P Music Nightbreath - Exept Unusual Behaviour - DLR Can't Hold - Kolectiv Afterlife - Phentix Pills - Atmospherix Monolith - Relict Step Back (Original Mix) - Walhack Back Pain - Brain RVE - Brain Cold Steppin (Ulterior Motive Remix) - Simple Technique Tribes - Monty Morning Walk - Scurrrow Trepi - M-zine, Jumpat, Spinline Ron Millonar - Foreign Concept Ghost Palace - Brendan &. Philth Pandora - Exept Just Fade Away - Reptile Perkithim - Scurrow Krakoin - Absurd Salt Factory Anthem - Qant Aquarius - Amor Satyr & Siu Mata Psychic Water - Amor Satyr & Siu Mata Lights Off - Amor Satyr & Siu Mata AHE - Amor Satyr & Siu Mata A Strange Story – Kercha, Low.r, Zygos Drained - Zygos Sous X - Zygos Likewise - RDG

Denmark is moving ahead on plans to introduce a carbon tax on agriculture, with cattle farmers facing additional charges as a result. The bill suggests that farmers would be taxed at 300 DKK ($70) per ton of CO2 equivalent emitted from 2030, moving to 750 DKK ($177) by 2035. The Country's Jamie Mackay says the farmers will be unlikely to take this lying down - and they love a good protest. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Denmark is moving ahead on plans to introduce a carbon tax on agriculture, with cattle farmers facing additional charges as a result. The bill suggests that farmers would be taxed at 300 DKK ($70) per ton of CO2 equivalent emitted from 2030, moving to 750 DKK ($177) by 2035. The Country's Jamie Mackay says the farmers will be unlikely to take this lying down - and they love a good protest. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Dagens episode er med vores gode kammerat og bestseller-forfatter, Nicklas Brendborg, der står bag bøgerne, Gopler Ældres Baglæns og Vanedyr. Husk endelig at gøre brug af rabatkoden "FREMTIDSFABRIKKEN", der giver alle førstegangsbrugere af GoMore 150 DKK til brug på plaftformen. Lease, udlej eller lej jeres bil på gomore.dk - det kører bare! Connect med os på LinkedIn: https://www.linkedin.com/in/larshorsbol/  https://www.linkedin.com/in/eskegerup/ 

Dagens episode er med en af de helt tunge herrer, nemlig Morten Primdahl, der er cofounder af Zendesk. En af de helt tidlige SaaS løsninger, der blev til en virksomhed med flere tusinde ansatte og en værdisætning på mange milliarder. Lyt med. En vild historie venter! Husk endelig at gøre brug af rabatkoden "FREMTIDSFABRIKKEN", der giver alle førstegangsbrugere af GoMore 150 DKK til brug på plaftformen. Lease, udlej eller lej jeres bil på gomore.dk - det kører bare! Connect med os på LinkedIn: https://www.linkedin.com/in/larshorsbol/  https://www.linkedin.com/in/eskegerup/ 

In this interview, we welcome the CEO of Novo Holdings, which manages the assets and wealth of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. Novo Holdings is part of the Novo Group, which also incorporates Novo Nordisk and Novonesis (who combined are responsible for much of Novo Holdings' inflows). Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Their purpose is to drive change to defeat serious chronic diseases, built upon their heritage in diabetes.  Novonesis, also part of Novo Group, serves 130 markets with enzymatic, microbial and advanced protein solutions. As of year-end 2023, Novo Holdings had total assets under management of €149bn (DKK 1,114 bn). In addition to managing a broad portfolio of equities, bonds & other assets, it also has a substantial allocation into life sciences.  In this illuminating discussion, Kasim shares Novo Holding's asset allocation, their corporate structure, the European regulatory context, their long term mission and the importance of the foundation's life-saving work. Kasim also covers balancing disbursements to the Novo Nordisk Foundation & re-investment in the fund, some criteria for working with external managers, their engaged ownership approach (especially in life sciences) and why they're comfortable as a public firm. He also discusses the challenge of increasing antibiotic resistance, how biology is assisting in the green transition and the breathtaking development of medical research (including the revolutionary role of AI in diagnostics). ​​The Money Maze Podcast is kindly sponsored by Schroders, IFM Investors and the World Gold Council. Sign up to our Newsletter | Follow us on LinkedIn | Watch on YouTube

I anledning af vores nye samarbejde med GoMore tager vi en køretur i rundt i den københavnske morgentrafik. For GoMore er ikke længere bare en samkørselsvirksomhed, nej nej. Det kommer vi meget mere ind på, i dagens episode som selvfølgelig er med Matias Møl Dalsgaard, direktør og stifter af GoMore. Matias har en ph.D i filosofi og det har fået os godt rundt om både GoMore, men også hvor idéen kom fra, om det er et større idealistisk foretagende eller om det egentligt er en smule opportunitisk? Og ingen samarbarbejde uden en rabatkode, så ved brug af "FREMTIDSFABRIKKEN" får førstegangsbrugere af GoMore 150 DKK til brug på plaftformen. Lease, udlej eller lej jeres bil på gomore.dk - det kører bare! Connect med os på LinkedIn: https://www.linkedin.com/in/larshorsbol/  https://www.linkedin.com/in/eskegerup/ 

Subdulgence track list: DKK. Deeptropix – Noshaq Fracture feat. Bryan Gee – Blaze Amplituda – Small Talk Sl8r – Buckfast at Tiffany's Jack Rupture – Spirits Of The Hex Future, If-Read – Hostel (Future Remix) Echo Brown – Stutter (Objectiv Remix) Delah – Downtown Delah – Orotund Benny L, Randall – II Worlds Delah – Music Is Life Delah – Upheaval Lupo – Déjà vu (Objectiv Remix) Philth – The Teacher (Bredren Remix) Lavance – Baba Yaga Delah – Perpetua Kusmo – Kraft Dinner Darkai – The Tempest Kercha – Cognitive Kilnical – Answer Para – In This House Leo Cap – How Did You Know That? Klinical – Violence Violence Ternion Sound – Verify Me VIP2 MOREOFUS – Likesss Stylust, Ashez – The Eleophant Thematic – Lookout Dominus – Teardrop Ape Suit – Tomorrow Or The Next Life q100, ØZ, FLO – Shakedown Mob Killa – Test Drive Traces – Originator Stocks. Midik - Clones (Original Mix) Alix Perez, Skeptical - Killa (Original Mix) Subp Yao, DAYLE - Oxygen (Original Mix) Monty - Gas Tank (Original Mix) Spinline, DLR - Please Stand Here (Original Mix) Zero T, Minor Forms - Second Guess (Original Mix) Incorporate - Tripping (Original Mix) nScape, Inva, M.Justa - Switch (Original Mix) Midik - Dem Dem (Original Mix) Phentix,QZB - Gang Signs (Original Mix) Teej, Objectiv - Astros & Jeans (Original Mix) Creatures,Jestah - Emulsifier (Original Mix) Nosia Ft Phace - Floating Zero (Original Mix) Rizzle, Nami Ongaku - Elektron Original Mix) Enei, QZB - Johannesburg (Original Mix) Ground - Second Contact (Original Mix) Enei - Imitate Process (Original Mix) Sinic Bitter Professional (Original Mix) Molecular - Funky Times (Original_Mix) Fre4knc & Klinical - The Shaman (Original Mix)

Mitochondria are called the powerhouse of the cells. They convert nutrients into energy, and they may hold the key to reverse aging and cure a large number of diseases. This is why exercise is important. But, can science one day come up with a pill that can reverse the aging of mitochondria? How close are we to solve this fundamental discovery? Shortly after this interview professor Zhen Yan received the Jacobæus Prize 2022 from the Novo Nordisk Foundation for his lifetime contribution to understanding of exercise for improvement of health. The Prize comes with 1,5 mio. DKK. Professor Zhen Yan from University of Virginia was interviewed by Science Journalist Jens Degett from Science Stories.

DKK

Welcome to Last Week in Denmark's official podcast.In this episode, hear Journalist, Wizzi Magnussen, and Founder of Last Week in Denmark, Narcis George Matache, present this week's newsletter headlines and deep dive into some of the below topics:2.3 billion DKK extra for the justice system400 million DKK allocated for strengthening psychiatry next yearDigital 'Stamp Clocks' for the employedChanges in the government - who are our three new ministers?Are you part of the top 1% of earners in Denmark?Sustainable purchasing to tackle climate change and more...Produced by Wizmedia

DNA and RNA sequence analysis enable researchers to form a total overview of which species of microorganisms and parasites live with humans, animals and plants. It is not just in our gut where microorganisms are playing a role in our digestion. Also on the skin and all mucous membranes, in the mouth and all the way down into the hair follicles, we live together with parasites and microorganisms which help to shape our lives and our development. This knowledge makes it possible to see organisms in a far more holistic perspective, which provides a far better understanding of the factors that have evolutionarily shaped the species as they now appear in nature. In this podcast, Science Journalist Jens Degett talks to Professor Marcus Thomas Pius Gilbert from the Center for Evolutionary Hologenomics (CEH) at the University of Copenhagen. The center received DKK 67.7 million from the Danish National Research Foundation. Photo credit: Jens Degett, © Science Stories ApS

On this episode of the AI For All Podcast, Jannick Malling, co-founder and co-CEO of Public.com, joins Ryan Chacon and Neil Sahota to discuss AI in finance and investing. They talk about what Public does, stock trading, how AI synthesizes financial data, the benefits of AI in investing, the impact of AI on investors and investing, how experienced investors are viewing AI, the new roles AI will create in finance, predicting the irrational behavior of people, and the risks of AI investing. Jannick Malling is the co-founder and co-CEO of Public, the investing platform that allows people to invest in stocks, ETFs, treasuries, crypto, art, collectibles, and more – all in one place. The Danish entrepreneur has a natural drive for making a difference. At the age of 17, he joined Saxo Bank. Two years later, he helped build the fintech company CFH Group, which was eventually sold to Playtech (LON: PTEC) for more than DKK 800 million. As part of CFH Group, he also launched the spin-off company Tradable, the world's first open API trading platform. In 2019, he founded Public, which has gone on to raise over $300 million from investors such as Accel, Lakestar, Tiger Global, Will Smith (Dreamers VC), and other prolific investors such as Maria Sharapova, Tony Hawk, and NFL stars J.J. Watt and Bobby Wagner, and more. Public is on a mission to make the public markets work for all people. The fintech went from founding to unicorn status in less than 3 years, and has been one of the fastest growing financial services apps in America, boasting more than 3 million members since its 2019 launch. 2023 will be a defining year, as this is the year Public has ventured beyond stocks and crypto investing into other asset-classes such as alternatives and fixed income products, and has taken the first steps in its international expansion. Discover more about AI at https://ai-forall.com More about Public.com: https://public.com (00:00) Intro (00:19) Jannick Malling and Public.com (00:27) What Public does and AI in investing (04:57) Advanced trading capabilities for retail investors (08:29) How does AI synthesize financial data? (12:10) Who benefits the most from AI in investing? (15:38) Is AI making people better or worse investors? (22:23) How is AI transforming the investing world? (26:12) How are experienced investors viewing AI? (30:16) What new roles will be created in finance by AI? (33:41) Predicting the irrational behavior of people (37:21) Risks in AI investing (40:43) Learn more about Public.com Subscribe on YouTube: https://bit.ly/43dYQV9 Listen to the Podcast: https://bit.ly/45rewGf Join Our Newsletter: https://newsletter.ai-forall.com Follow Us on Social: https://linktr.ee/aiforallofficial

Welcome to Last Week in Denmark's official podcast.In this episode, hear Journalist Wizzi Magnussen and Founder of Last Week in Denmark, Narcis George Matache present this week's newsletter headlines, a political over and deep dive into some of the below topics.Topics covered include: Interest rate increaseInflation is stabilizingTax increase for people living in Frederiksberg1200 nurses from IranOfficial apology from the governmentYou can continue to buy cans without pant / deposit from the border storesHomeschooling is attracting Germans to Denmark360 million DKK for adult educationThe war against gangs intensifies Property assessmentsand more...Produced by Wizmedia.

I panelet finder du Morten Wichmann, Jacob Wilson, MC og Michael Schøt. Mikkel tager værtstjansen og guider dig igennem Saudi Arabiens fodboldindkøb, Zelenskys besøg, Dennis Knudsens meltdown og de unges drukvaner. 'Afsnittet er optaget live på Comedy Zoo og vi vil så gerne have, at du kommer og til næste liveshow, hvor der også er stand-up! Det er d. 5. september - find billetterne på www.comedyzoo.dkKærlig hilsenMichael og MikkelKlip & mix: Kaspar Bang Hosted on Acast. See acast.com/privacy for more information.

Welcome to Last Week in Denmark's official podcast.In this episode, hear Journalist Wizzi Magnussen and Founder of Last Week in Denmark, Narcis George Matache present this week's newsletter headlines, a political over and deep dive into some of the below topics.Topics covered include: Legality of the Danish borders300 million DKK for vocational schoolsWages and TaxesSupport for the ban on burning religious books in public spaceDanish population, fifth richest in the worldEurovision for the Artic regionsSocial media use in Denmark Legalising cannabis in GermanyLGBT+ rights, rainbow families, blood donations & the first drag school in Denmarkand more...Produced by Wizmedia.We are proud to open this episode with our new jingle and thank all those who donated to its creation. Our sound was composed by Jack Leatherbarrow from Wizmedia. 

På Facebookannoncering.dk har vi lavet et BigQuery-dashboard, der hiver tal for samtlige kunder i Obsidian Digital. Vores kunder bruger ca. 400 mio. DKK om året på Facebook- og Instagram-ads. Vi har lavet siden for at du som annoncør altid kan trække nogle trends med udgangspunkt i det danske marked og danske virksomheder for fx CPM, CPA og CPC. Grafen her viser den gennemsnitlige CPA (Pris per Køb) for samtlige kunder i Obsidian Digital de sidste 12 måneder. I den periode har vi set st stødt fald fra 35 EUR til 19 EUR - altså et fald i gennemsnitlig CPA på 46%! Det betyder, at vores gennemsnitlige kunder i dag betaler 46% MINDRE for et køb end for et år siden på Meta. Der er flere grunde til, at annoncering på Facebook og Instagram lige nu brager igennem: ✔️ Meta er lykkes rigtigt godt med at få folk til at bruge mere tid på app'en, særligt i Reels. Den "skjulte" investering i AI (ifht. den meget synlige investering i Meta-verset) betaler sig. Antallet af sidevisninger er oppe, og så falder CPM-prisen, hvilket trækker CPA-prisen ned. ✔️ Meta - og resten af industrien - fik et slag med iOS14. Men Meta har taget skeen i den anden hånd og har forbedret modellering, lanceret Advantage+ der er baseret på on-platform signaler, skubbet på implementering af serverside tagging / Conversions API og i det hele taget bare arbejdet sig igennem udfordringerne. ✔️ Forbrugertillidsindeks-tallene i Danmark bundende omkring september/oktober 2022 og nu er vi steget 8 måneder i streg. Folk er mindre bange for fremtiden og bruger derfor flere penge her og nu. Min fornemmelse er, at annoncering på Facebook og Instagram tog et ordentligt slag i april 2021 pga. iOS14/ATT, og at vi siden da har været underdrejet. Men jeg tror faktisk, at vi er ved at være der. Jeg er meget bullish ind i efteråret for danske virksomheder (og webshops, som grafen her er baseret på). Hvad betyder det for dig? Du burde have markant bedre resultater lige nu end for et år siden. Hvis ikke, så bør du kigge ind i dit setup med kritiske øjne. Meta har potentiale til at spille en stor rolle i den vigtige Q3 og Q4-planlægning. Hvis du har nogle penge til overs, så kan du placere dem i Meta-aktier, for jeg tror den kommer til at sige (det skal jeg lidt sige: det er min egen største position ;-) )

In this week's episode, we have special guest De Kleine Kapitalist (DKK) with us. DKK is passionate about high-quality compounders that pay growing dividends. That's why he's joining us today to talk a bit more about Irregular Dividend Compounders. But before we get to that, we will first discuss the news of the week which is about Ahold Delhaize ($AMS:AD). After that, we'll jump right into our main topic of the day. DKK will introduce us to the Irregular Dividend Compounders term followed by two examples and how much % of his portfolio is allocated to such stocks. After that we will answer several questions from the community and at the end we will hear more about DKK's stock pick of the week. We hope you enjoy today's show and C U on the inside! --- Google Tickers mentioned in the show: AMS:AALB, STO:THULE, EPA:LVMH, AMS:BESI, ETR:ALV, LON:LGEN, AMS:ASRNL, AMS:ASML, EPA:OR, LIN, EPA:LVMH, LON:DGE, STO:ASSA-B, CPH:NOVO-B, AMS:WKL, EPA:EL, EPA:SU, ECL --- Follow De Kleine Kapitalist on Twitter: https://twitter.com/dekleinekapita1 Read his blog here: https://dekleinekapitalist.nl/ His article about Ecolab: https://dekleinekapitalist.nl/dividendaandeel-ecolab/ --- Follow us on FaceBook: https://www.facebook.com/groups/dividendtalk

Vinene i dette afsnit er skænket af Vindica Wine https://vindica.wine/   Smagekasse med 12 stk svarende til 4 flasker vin  https://vindica.wine/products/discover-vindica-the-innovative-pack   ……………   Der bliver skrevet historie i dette afsnit, da vi for første gang skal smage vin på dåse. Vi skal smage Riesling fra Pfalz i Tyskland, Garnacha Blanca og Grenahe fra Cariñena i Spanien.   Smager vinen anderledes fra dåsen end når den er på flaske?   Hvad er forskellen på en glasflaske og en aluminumsdåse egenskaber til vinopbevaring og hvilke fordele findes der ved at have vinen på dåse?   Hvordan ser CO2 aftrykket ud ved vinfremstilling, hvad er den store synder og hvordan kan aftrykket reduceres?   Hvordan er garnacha blevet til garnacha blanca og hvordan vinificeres den traditionelt?   Vi fremlægger desuden en masse tal som man se her. - 65% CO2 reduktion (3 x 250 ml. aluminiumsdåse vs. 750 cl glasflaske) (kilde Systembolaget / Gaia insights   - Cirkulær økonomi - Aluminum kan genbruges “for evigt” eller i hvert fald meget lang tid. Fra miljøstyrelsen: “For aluminium vurderes det teoretiske genanvendelsespotentiale at være 100%... Det vurderes dog kun at være praktisk muligt at indsamle cirka 95% af mængden, hvilket betyder at det realistiske genanvendelsespotentiale bliver 95%...”   - Det estimeres at 75% af alt aluminium der nogensinde er produceret stadig er i brug i dag (siden kommercielt introduktion i 1860)   - I 2009 blev der i UK hældt vin i vasken til en værdi af mere end 3,8 milliarder DKK.   Til slut går vi retro og snakker om begreber til at beskrive smagen på vin.   Vi smager på   1) Riesling, Frank John, 2022 https://vindica.wine/collections/frontpage/products/riesling   2) Garnacha Blanca & Moscatel, Libre y salvaje, 2021 https://vindica.wine/collections/frontpage/products/libre-y-salvaje-garnacha-blanca-orangevin   3) Grenache, Libre y salvaje, 2020 https://vindica.wine/collections/frontpage/products/grenache   ..................   Støt Vin for begyndere podcast her https://vinforbegyndere.10er.app/   Køb bogen Vin for begyndere her: http://vinforbegyndere.com/   Besøg os på Facebook og Instagram, hvor man kan se billeder af vinene og få tips til vin og mad sammensætning.   https://www.facebook.com/vinforbegyndere   https://www.instagram.com/vinforbegyndere   Web: https://www.radioteket.dk/   Kontakt: radioteket@radioteket.dk   Musik: Jonas Landin

Renteprognosen er opjusteret markant, efter prognoserne for Fed, ECB og Nationalbanken igen er opjusteret betydeligt. Prognosen for ECB og Nationalbanken er nu meget tættere markedsprisningen, mens prognosen for Fed er mere dueagtig end indpriset især for 2024. Derfor er prognosen, at stats- og swaprenter i USD, EUR og DKK falder mere end indpriset i løbet af prognoseperioden med kurvefladning på kort sigt, mens rentekurver stejler, når rentenedsættelserne i 2024 kommer nærmere. Læs hele prognosen her.

Sådan sparer du DKK 2000 hver måned (Video: 11 min.) Affald er det nye guld! Vidste du, at vi smider 20% af al vores mad ud !?? Det er jo helt gak / helt vildt / totalt åndssvagt I dagens modul 3+ fortæller Jakub om konceptet 'at skralde', også kaldet 'dumpster diving' på engelsk. Det er et rigtig spændende emne, ikke bare fordi man på den måde kan spare mange penge, men også fordi man også passer på klimaet ! At undgå madspild ved at skralde er således en rigtig god måde at være miljøvenlig på Tak for den virkelig god præsentation, Jakub ! Næste gang skal vi tale om 'at betale skat i Danmark' - jeg glæder mig allerede PS: her kan du læse Jakubs tekst om at skralde: At skralde. Jeg hørte om ‘dumpster diving' (eller om at ‘Skralde' på dansk) for mange år siden. Jeg startede først med det i 2021, da jeg flyttede til København. Det var fordi jeg havde ikke et job på det tidspunkt. Det var en interessant Instagram profil, som hedder ‘Urban Harvester', som inspirerede mig. Cirka 20 % af al mad i EU bliver faktisk til skrald og bliver smidt ud. Men for mig var det vigtigste, at jeg ikke havde penge. Nu er jeg tilbage med at skralde. Igen fordi jeg ikke har nogen penge. Jeg tager til forskellige supermarkeder, men for det meste til Netto. Nettos affald er normalt ikke aflåst eller gemt væk. Jeg kan fx let finde bagværk fra dagen før, frugt og grøntsager som har nogle defekter og salater som er udløbet. Du skal være rigtig forsigtig, så du ikke bliver syg. Jeg har altid arbejdshandsker på, og jeg bruger altid håndsprit. Jeg finder så meget mad, at jeg faktisk kun behøver at købe: mælk, saft og kød. Jeg er virkelig glad for det, fordi det måske sparer mig cirka to tusind kroner om måneden. Og også fordi jeg hader madspild.

“Egy őszinte, gyerekhangtól élénk, otthonos környezet a mi óvodánk. Amit mi itt adunk az nem megfogható, mutogatható, Instagramra felrakható likevadász képsorok. Gyakori kérdések: Van az óvodában tenisz, vívás? Sószoba? Visszük színházba, hangversenyre? Óvoda végére leteszi a középfokú angol nyelvvizsgát? Ha kizárólag a fentieket keresi a gyermekének, akkor ne minket válasszon. A hangsúly itt máshol van. Érzéseken. Gondolatokon. Kapcsolatokon. Igazi gyermeki tevékenységen. Ahol a materiális szemlélet helyett, a belső értékek kapnak elsőbbséget. A fiúk megtanulják előre engedni az ajtóban a lányokat, a lányok pedig megköszöni és elfogadni ezt a gesztust. Nagycsoportosként megvigasztalni az anyukája után szipogó kiscsoportost. Észre venni, ha valakinek segítségre van szüksége. Örülni a másik sikerének. Előre köszöni a házban lakó idős hölgyre. Igen, ezek mind mi vagyunk. A gyerekek egy reális képet kapnak az erősségeikről és azokról a területekről is, ahol megsegítésre van szükségük. Nem akarjuk megmenteni őket az élettől, megtanítjuk őket benne élni. A módszerünk hármas alappillére: a DKK. Differenciálás, kooperáció és kommunikáció.” Oly egyértelmű mindez, ma már mégis kuriózum.

Lars Nordal Jensen is the Director of Fund of Funds investments at Vaekstfonden, the Danish Growth Fund.Since 1992, The Danish Growth Fund has financed more than 5,400 Danish companies with a total commitment of more than €1.5 billion. The Danish Growth Fund invests equity and provides loans and guarantees for small as well as medium-sized enterprises in collaboration with private partners and Danish financial institutionsWe discuss:- The role of sovereign/government funds in the EU Venture Capital scene- Analysis of sovereign funds terms and trends- The LP takes on today's Climate Tech ecosystem--------------ABOUT CLIMATE INSIDERS:Climate Insiders is brought to you by Climentum Capital, a Seed+ and Series A cleantech European venture capital firm focused on funding and scaling climate-positive ventures that cut down on CO2 emissions.If you are interested in how smart capitalism combined with mission-driven founders building innovative tech startups can overcome our climate crisis and build a better future, you've come to the right place.Check us out at: https://www.climateinsiders.co and https://www.climentum.com--------------ABOUT THE GUEST:Lars Nordal Jensen is the Director of early stage and Fund of Funds investments at Vaekstfonden, the Danish Growth Fund.Since 1992, The Danish Growth Fund has financed more than 5,400 Danish companies with a total commitment of more than DKK 15 billion. The Danish Growth Fund invests equity and provides loans and guarantees for small as well as medium-sized enterprises in collaboration with private partners and Danish financial institutionsLars has been with VF for more than 10 years now, occupying multiple roles.--------------SHOW NOTES:00:00 - Introduction02:07- Start03:30 – How does a government fund function?04:26 – Is the EU VC Industry high on soft money?06:18 – What is the situation like in the U.S. and Asia?06:53 – How does the EU reduce the dependency on government funds?09:00 – How could government funds compress the time it takes to deploy capital to funds?11:53 – Is it desirable to stretch the time of funds to create a market barrier?13:29 – Are national quotas a bad thing and should they be abolished?16:30 – Is there a fear that sovereign funds might crowd up the market?19:03 – Should sovereign funds cooperate more across Europe?20:45 – How could government funds help increase diversity?23:45 – Is there too much capital investment in green and sustainable innovation?24:53 – Is it still a good moment to invest in Climate Tech?25:50 – Does it make sense to invest only in Article 9 funds from now on?27:11 – What can investors do to avoid “greenwashing”?29:08 – Value that Article 9 brings31:01 – Dual carry structure32:40 – Rapid Fire Round--------------ABOUT THE HOST:Yoann Berno https://www.linkedin.com/in/yberno/ After a career spent building and investing in top tech startups, Yoann is now a founding member and General Partner at Climentum Capital focused on investing in game-changing technological solutions to our worsening climate crisis.--------------To learn more about CLIMENTUM CAPITAL and apply for funding, please visit https://www.climentum.comTo become an LP and invest in one of Climentum's upcoming funds, get in touch at: https://www.climentum.com/contact-formAnd don't forget to SUBSCRIBE to our NEWSLETTER at https://www.climateinsiders.coTWITTER: https://twitter.com/Climentum LINKEDIN: https://www.linkedin.com/showcase/climate-insidersLars Nordal Jensen https://www.linkedin.com/in/lars-nordal-jensen-4101882Vaekstfonden https://www.linkedin.com/company/vaekstfonden/

Am letzten Tag des DKK 2022 sprechen Harald Müller-Huesmann (Paderborn) und Anke Reinacher-Schick (Bochum) über Leidenschaft und Engagement in der Krebstherapie. Als multiprofessionelles Arbeitsumfeld muss die Onkologie jetzt und in Zukunft zeigen, dass die Arbeit für alle Beteiligten sinnstiftend ist. Für eine optimale Versorgung von Patientinnen und Patienten sollten Computer das Personal in Klinik und Praxis entlasten. Auch nach der COVID-Pandemie muss die Digitalisierung daher weiterhin auf Kurs gehalten werden. Denn wie in anderen Fachbereichen, ist der vernünftige Einsatz von Ressourcen ebenfalls in der Onkologie von hoher Relevanz. Hören Sie die Sonderfolgen rund um den DKK und abonnieren Sie auf den einzelnen Streaming-Plattformen die Onko-News aus Berlin. Werden Sie pünktlich zum Frühstück informiert: Tägliche Erfahrungen, Neuigkeiten und Schilderungen von vor-Ort-Erlebnissen!Melden Sie sich für E-Mail-Benachrichtigungen an, um keine neue Folge zu verpassen. Klicken Sie hier und gelangen Sie zum Roche-Podcast-Portal. Das Fachportal von Roche finden Sie hier.

Der Deutsche Krebskongress zeigt noch einmal auf, dass es im Bereich der onkologischen Versorgung viel zu tun gibt und dass Veränderungen erst dann eintreten, wenn die beteiligten Akteure sektorenübergreifend zusammenarbeiten. Harald Müller-Huesmann (Paderborn) begrüßt Benedikt Westphalen (München) am Mikrofon und spricht mit ihm unter anderem über die Präzisionsonkologie: Wie kann die Versorgung in Deutschland gelingen und wie kann all das, das auf internationalen Kongressen vorgestellt wird, letztlich bei Patientinnen und Patienten ankommen? Was Teamwork und ein toller Spirit zudem bewirken können und wie wichtig es in der Behandlung ist, motivierte Menschen um sich herum zu haben, erfahren Sie in einer weiteren Podcast-Folge aus Berlin.  Hören Sie die Sonderfolgen rund um den DKK und abonnieren Sie auf den einzelnen Streaming-Plattformen die Onko-News aus Berlin. Werden Sie pünktlich zum Frühstück informiert: Tägliche Erfahrungen, Neuigkeiten und Schilderungen von vor-Ort-Erlebnissen!Melden Sie sich für E-Mail-Benachrichtigungen an, um keine neue Folge zu verpassen. Klicken Sie hier und gelangen Sie zum Roche-Podcast-Portal. Das Fachportal von Roche finden Sie hier.

In der zweiten Sonderfolge anlässlich des 35. DKK spricht Harald Müller-Huesmann (Paderborn) mit Claas Lahmann (Freiburg). Wie Arbeit und Gesundheit Hand in Hand greifen, und welchen Stellenwert die Psychoonkologie bei der Therapieversorgung besitzt, diskutieren die beiden Gesprächspartner im heutigen Podcast. Denn auch im klinisch-onkologischen Umfeld ist der Fachkräftemangel spürbar festzustellen: der demographische Wandel, die COVID-Pandemie und veränderte Arbeitsbedingungen sind dabei nur ein Teil der Gründe. Doch was unternehmen? Wie kann sichergestellt werden, dass Patientinnen und Patienten auch psychoonkologisch weiterhin die Versorgungsleistung erhalten, die ihnen zur Verfügung gestellt werden sollte? All dies erfahren Sie im aktuellen Podcast.Hören Sie die Sonderfolgen rund um den DKK und abonnieren Sie auf den einzelnen Streaming-Plattformen die Onko-News aus Berlin. Werden Sie pünktlich zum Frühstück informiert: Tägliche Erfahrungen, Neuigkeiten und Schilderungen von vor-Ort-Erlebnissen!Melden Sie sich für E-Mail-Benachrichtigungen an, um keine neue Folge zu verpassen. Klicken Sie hier und gelangen Sie zum Roche-Podcast-Portal. Das Fachportal von Roche finden Sie hier.

Nach den Podcast-Sonderfolgen aus Chicago und Paris begrüßt Sie Harald Müller-Huesmann die kommenden Tage aus Berlin. Der 35. Deutsche Krebskongress (DKK) öffnet vom 13. bis 16. November 2022 seine Türen. Grund genug für den Paderborner Mediziner, ein weiteres Mal mit Mikrofon und Aufnahmegerät loszuziehen. Onkologische Themen diskutiert er mit verschiedenen Gesprächspartner:innen auf lockere und unterhaltsame Art. In der ersten Folge sprechen Harald Müller-Huesmann und Georg Isbary (Roche Pharma AG) unter anderem über die Unterscheidung des DKK zu internationalen Kongressen wie dem ASCO und ESMO. Was erste Highlights des Kongresstages waren, wird ebenso ausgeführt wie die Frage, was Deutschland unternehmen muss, um als relevanter Spieler in der onkologischen Forschung und Therapie weiterhin Position zu zeigen. Hören Sie die Sonderfolgen rund um den DKK und abonnieren Sie auf den einzelnen Streaming-Plattformen die Onko-News aus Berlin. Werden Sie pünktlich zum Frühstück informiert: Tägliche Erfahrungen, Neuigkeiten und Schilderungen von vor-Ort-Erlebnissen!Melden Sie sich für E-Mail-Benachrichtigungen an, um keine neue Folge zu verpassen. Klicken Sie hier und gelangen Sie zum Roche-Podcast-Portal. Das Fachportal von Roche finden Sie hier.

Jonas har langt om længe fået omkring nr. 1 på wantlist over plade hjem. Tim Maia - Vol. 2. En brasiliansk soulet og funket hellig gral som normalt koster 5-6000,- DKK i god stand. Men den er blevet fundet til omkring en tredjedel, dog i en lidt tvivlsom stand. Så der blive krydsklippet mellem den digitale udgave og vinylen, som ovenikøbet har været igennem DR Diskotekets højteknologiske pladerenser. At købe en plade for så mange penge i sådan en stand må vel kaldes irrationel pladekultur, som Jonas dog med næb og klør prøver at forklare bevæggrunden for. Udover det: musik fra Tyskland, Sydafrika, Ghana og Libanon. Og PS! så er det sidste udsendelse fra DK før vi i næste uge rykker produktionen til Ghana!

Bonusová část je k dispozici na Herohero.Genetiku si možná ze základky pamatujete jako to šíleně složité téma, které šlo úplně mimo vás. Přesto by ale každý majitel psa měl mít aspoň základní povědomí o hlavních pojmech a souvislostech, zejména potom když se chystá svého psa nebo fenu uchovnit a třeba odchovávat štěňata.Proto jsem se rozhodla jí věnovat samostatnou epizodu podcastu a pevně věřím, že se nám podařilo s Terezií Valčíkovou vybrat z téhle obrovsky široké oblasti ty zásadní věci a otázky, které si chovatelé psů kladou.V podcastu mimo jiné probíráme:– proč by se měl v základech genetiky orientovat každý majitel psa?– jak funguje genetické testování na konkrétní nemoci, co se dá testovat a co má smysl testovat?– základní genetické pojmy a jejich vysvětlení – gen, alela, fenotyp, genotyp a další– jsou voříšci opravdu zdravější než čistokrevní psi s PP?– jak to funguje s dědičností barev?– jak je to s dědičností DKK, DLK a dalších– co je to inbreeding, koeficient inbreedingu a proč by nás měl zajímat– jak vlastně probíhá genetické testováníLíbí se vám podcasty Pejskárium® a chcete je mít k dispozici ještě dříve včetně bonusů? Přidejte se do Pejskárium fanklubu na Herohero! To je česká platforma, díky které můžete v ceně jednoho kafíčka měsíčně podpořit moji tvorbu a vznik dalších dílů tohoto podcastu. Na oplátku dostanete vstup do kompletního archivu bonusových materiálů a spoustu dalších výhod :-).Jestli vás zajímá víc podobných příspěvků, článků a tipů do života se psem, budu se na vás těšit na www.pejskarium.cz!Za střih a úpravu podcastu děkuji Terezce, která stojí za projektem "Kreativní brejloun",  její krásné psí ilustrace najdete na Instagramu.Podcast můžete v aplikaci Apple podcasts během pár vteřin ohodnotit a dát mi tak zpětnou vazbu, zda se vám rozhovory líbí.Poznámka pod čarou: Rozhovory v podcastech reprezentují také osobní názory hosta, které se vždy nemusí shodovat s tím, co šířím sama za sebe v rámci svých dalších kanálů. 

“When you are enthusiastic about what you do, you feel this positive energy.  It's very simple” -Paul Coelho In 2021, the LEGO Group delivered record-breaking business results with revenue jumping +27% to 55.3 billion DKK and operating profit going up +32% to 17.0 billion DKK. Fueled by their mission to “Inspire and develop the builders of tomorrow” the LEGO Group has mastered taking the long view on getting every child in the world to experience LEGO play.  But how do LEGO leaders engage employees' day to day with such a loft, long-term vision?In this edition of the “Leading from Purpose” podcast, Nick Craig introduces listeners to Victor Saeijs, Regional President for Western Europe at the LEGO Group.  His purpose?  To “Be the Duracell Bunny that makes my team sell boats in the Sahara.”  In this lively repartee, Victor describes how he uses  challenging goals and new ways of working to make the impossible possible, challenging his team to reach new levels of performance while simultaneously pushing himself to new heights.  Hear how Victor's tapped into this approach to capitalize on opportunities throughout his career and gain an appreciation for the LEGO Group's newest challenge—helping children learn 21st century skills by making a significant contribution to learning and education.  

Efter en mindre USD-svækkelse siden november, primært på amerikansk aktieuro, forventer vi en stærk og yderligere overvurdering af USD indtil efteråret 2022. Strukturel efterspørgsel efter amerikanske aktier, stigende præmier for adgang til USD og pengepolitiske renteforhøjelser skal trække USD stærkere mod EUR 1,10 og DKK 6,76.Læs hele prognosen her.

I dette første afsnit i 2022 taler vi om, hvordan vi kan holde og nå de mål, vi sætter os. Stiller vores selvbillede sig måske i vejen for, at vi rent faktisk finder en kæreste, taber de sidste kilo eller opnår det mål, som vi har sat os? Og hvordan ændrer man så det selvbillede? Recreate You: https://www.facebook.com/recreateyou.dkKærlighedens Labyrint på Instagram: https://www.instagram.com/kaerlighedenslabyrint/

Unicorn-potentiale!!! Vi har Anne Weichenfeldt Steenberg med i studiet. En vaskeægte iværksætter der står med fingrene i mulden og er på et stadie der minder om et sted mellem Lars og jeg! En fantastisk spændende rejse Anne har været på hvor hun bl.a. fortæller om overvejelserne ved at springe ud som iværksætter i 30'erne, have børn og partner imens og balancere det hele med et start-up hun nu er all-in på!Favoritter:App: Instagram/LinkedInLivret: Brun sovs og sushi (ikke på samme tid)Bedste køb under DKK 1000: Aldo stilletter pinkBog: Glad kunde / sur kunde - William AtakFeedback modtages med kyshånd. Del Del Del.Connect med os på LinkedIn:https://www.linkedin.com/in/larshorsbol/https://www.linkedin.com/in/eskegerup/ See acast.com/privacy for privacy and opt-out information.

Hvad gør man, når man som ny leder får til opgave at sætte sine nye medarbejdere ned i løn og op i tid? Det lyder ikke rart, vel? Den opgave har Lise stået overfor, og hun fortæller her i den korte introduktion hvordan hun reagerede, og hvorfor historien er vigtig ift. konflikthåndtering. Besøg Lises hjemmeside: www.liseterp.dkKøb hendes bog "Spind guld på konflikthåndtering":

From electrician to car painter to business owner. Randy has been involved with re launch of DKK car club. From the early 80s till now he's had the VW passion running through his veins. Hear the story of Der Speed Shack. The difficulties trying to  start a small parts shop in todays world. Growing up in Fullerton and cruising Whittier Boulevard. Follow randyinstagram    

Renter er steget og rentekurver er stejlet, efter signaler om opstramninger af pengepolitikken er blevet mere moderne især i Fed og BoE. Vi vurderer, at renter kan falde på kort sigt, men venter stadig stigende renter i 2022 – dog mere i USD end i EUR og DKK, da ECB ventes at opstramme langsomt.Stigende renter og stejlere rentekurverHøgeagtige signaler fra Fed presser renter højereECB strammer langsomt opStigende danske renter og stejlere rentekurverHøjere danske realkreditrenteLæs hele prognosen her

On this week's ESI Digest, we cover Naz Aletaha's major Riot Games promotion, Rivalry entering the TSX Venture Exchange, Galaxy Racer expanding into Pakistan, Immortals's Nitto Tire partnership, plus GN Store Nord's DKK 8bn acquisition of SteelSeries. Read these stories and more at EsportsInsider.com.

Kronerenterne siver resten af i år, men der er ingen udsigt til, at rentespændet til EUR bliver betydende negativt. I det lys forventer vi, at DKK bliver ved med at handle nær Nationalbankens interventionskurs 7,436Læs mere her.

Rick Meredeth has been part of the Southern California VW scene since the mid-seventies. Getting exposed to the California-Look wasn't too difficult. His 1967 Savana Beige car has been in his life for over 40 years. Hear about how he got into DKK & some of the history of the 70's 80's area of the VW scene. What happens when you wreck your VW find out how rick stayed connected to the scene & how the club starts to grow again. To buy merchandise https://www.letstalkdubs.com/store.html   Link to Blog page

Forhjulslir præsenteres i samarbejde med Oddset fra Danske Licens Spil +18. Denne etape er optaget torsdag den 22. april som en Facebook live-udsendelse på Continentals Facebook-side. Vi har talt om det før, #ShareTheRoad - og det bliver vi ved med! Tour De France kommer til Danmark i 2022 – et historisk event, der med garanti vil trække et stort antal cyklister ud på landevejene! Det er her, at vi skal blive bedre til at dele vejen, både motionister og bilister – så der er plads til alle. Brian Holm (sportsdirektør for Deceuninck-QuickStep), Mathias Norsgaard (professionel cykelrytter for Movistar), Alex Pedersen (Direktør for Grand Depart København & Danmark) og Camilla Lykke (triatlet) gæster viften på dagens etape. På dagens etape snakker vi netop om sikkerheden på landevejene, #ShareTheRoad og hvordan vi alle - cyklister og bilister - har et fælles ansvar. Derudover sætter vi fokus på den danske Tour de France-start i 2022, hvor Alex Pedersen blandt andet fortæller om, hvordan lille Danmark kunne lokke verdens største cykelløb til. Men også om, hvilken betydning TDF-starten har for Danmark og dansk cykling.  Udover en masse gode snakke, afslører vi en stor præmie: En Merida Scultura Carbon cykel – udstyret med SRAM ETAP 12 speed og top lækre VISION fælge, til en værdi af 40.000 DKK! Følg/synes godt om Forhjulslir og Continentals Facebook-sider for at finde ud af, hvordan du kan deltage i konkurrencen om den lækre cykel. Medvirkende: Alex Pedersen, Brian Holm, Mathias Norsgaard, Camilla Lykke og Anders Mielke Læs mere om #ShareTheRoad her: sharetheroad.dk Se eller gense Facebook live-udsendelsen her: https://www.facebook.com/ContinentalDK/videos/465493787984489

DNA and RNA sequence analysis enable researchers to form a total overview of which species of microorganisms and parasites live with humans, animals and plants. It is not just in our gut where microorganisms are playing a role in our digestion. Also on the skin and all mucous membranes, in the mouth and all the way down into the hair follicles, we live together with parasites and microorganisms which help to shape our lives and our development. This knowledge makes it possible to see organisms in a far more holistic perspective, which provides a far better understanding of the factors that have evolutionarily shaped the species as they now appear in nature. In this podcast, Science Journalist Jens Degett talks to Professor Marcus Thomas Pius Gilbert from the Center for Evolutionary Hologenomics (CEH) at the University of Copenhagen. The center has recently received DKK 67.7 million from the Danish National Research Foundation. Photo credit: Jens Degett

Traditionen tro er vi tilbage med årets julespecial 2020. Afsnittet er ekstra godt i år, nu hvor I blev snydt for en julespecial i 2019! I afsnittet kommer vi omkring StockX's værdi på 17 mia. DKK, den kommende Supreme x Nike AF1 “Flax”, samt genudgivelsen af Kobe 6 “Grinch” fra 2010. Samtidig runder vi året af med et indblik i vores bedste køb i 2020, de værste releases, det mest skuffende brand og meget mere. Tak for at have lyttet med i 2020! Vi håber, at I vil lytte med igen næste år.

I dagens udsendelse tager Kristoffer Kjær Lomholt (vært) sammen med gæsterne Lars Sparresø Merklin og Mikael Olai Milhøj et kig frem mod 2021. Hvad er det makroøkonomiske og politiske baggrundstæppe? Hvordan ser det ud med en vaccine, og skal vi forvente, at SEK, EUR og dermed DKK igen vil være blandt de valutaer, som styrkes mest på bekostning af f.eks. USD? Inden de spørgsmål besvares, tages først et kig tilbage på 2020. Hvad vil deltagerne f.eks. primært huske dette historiske år for på valutamarkederne?

Un morceau de rouge Bourgogne, merci (KONKURRENCE AFSNIT) 15 afsnit inde i podcasten kommer vi endelig til Bourgogne. Denne gang er det rød bourgogne fra Corte D'or, nærmere bestemt Beaune. Vinene er præget af mineral, rød frugt og de virker stadig meget ungdommelige.  Vinene er produceret af et ungt supertalent! Pierre Girardin, der har lavet et moderne, "State of the art" vinhus, er dagens mand i skysovs ;) Vinene er Pierres 1. og 2. årgang og kvaliteten er kommunerødvin fra henholdsvis Pommard, Volnay og Aloxe-Corton.  Dagens sponsor er: www.eriksorensenvin.dk Dagens vin: Pierre Girardin, Pommard,       DKK 700 Pierre Girardin, Aloxe Corton  DKK 550 Pierre Girardin, Volnay             DKK 650   Tak fordi du lytter med, uden dig ingen vin i glasset!  

A pool of 1.000000 DKK to realize your ideas, you can apply in groups or alone. We talk about the rules and what you should focus on. Lasse Mortensen from the Rectors Secretariat at SDU in an interview.Deadline for applications 1 OctoberInfo Meeting on 17 SeptemberLink to the application form and webpage: https://mitsdu.dk/en/voresverdensmaal/voresverdensmaal_nyhedsliste/verdensmaalspuljeTotal run 18:45 minutesSpeakers: Katharina Rubahn, Lasse MortensenIntro text spoken by Christian Sollberger, https://www.speech-academy.com/Intro music created by sscheidl from PixabayOutro music: Nature Documentary - GEMAfreie Musik von https://audiohub.de

Endelig lot det seg gjøre. Hele redaksjonen i DKK er samlet for en podcast slik den var ment til å være. I studio svarer Martin, Jonas og Mats på spørsmål fra lyttere og forteller om hvordan de fikk tiden til å gå i karantenen

(6. maj 2020) I dag stiller vi skarpt på de skandinaviske valutaer. En fælles faktor for NOK, SEK og DKK er fortsat globale forhold drevet af især genåbningen af de vestlige økonomier; ikke mindst aktiemarkedet - og deraf følgende valutariske flows – vil sætte retningen for de tre. Men der er også forskelle. Hvad er hemmeligheden bag den fortsatte NOK-styrkelse? Hvad betyder Riksbankens nulrente-politik for SEK? Og hvordan påvirkes DKK af, at staten nu optager gæld i udenlandsk valuta? I dag er Jens Nærvig Pedersen og Kristoffer Kjær Lomholt gæster hos Christin Tuxen.

About MeToo in resurrection of the Christ. I believe, that women in particularly can celebrate Easter as a feminist holiday, whether they believe in God or not. To support this podcast, you can donate as little as 5 DKK per episode at https://notyourrib.10er.app

Practice of making and using cosmetics is often criticized for being imposed on women by capitalists. This episode of “Not Your Rib” challenges that point of view.   To support this podcast, you can donate as little as 5 DKK per episode at https://notyourrib.10er.app

Valutamarkederne præges fortsat af udviklingen i relation til coronavirus. Hjælpepakkerne fortsætter med at komme i en lind strøm – og specielt i USA har man fundet det store skyts frem pengepolitisk og nu også finanspolitisk. USD vil formentlig stryge tilbage over 7 mod DKK på den korte bane. Men hvad skal man være opmærksom på længere ude? Og er der nu endelig stabilisering på vej i de skandinaviske valutaer NOK, SEK og DKK? I dag er Kristoffer Kjær Lomholt gæst hos Christin Tuxen.

Was können Onkologen beruflich eigentlich abseits von Kliniken machen und wie sieht es mit der Work-Life-Balance von jungen Ärzten aus? Christoph Oing und Caroline Peuker erzählen es beim Deutschen Krebskongress (DKK) in Berlin. 2018 haben beide die Junge DGHO zu gründen, um eine Interessenvertretung für junge Onkologen zu etablieren. Und sie erzählen ihren persönlichen Eindruck, warum sich Kongresse wie der DKK lohnen.

Als Einzelkämpfer geht es auch, aber im Netzwerk geht es einfacher: Timo Frank von der Organisation Hashtag Gesundheit versucht Studenten, Azubis und Berufseinsteiger im Gesundheitswesen zum Netzwerken zu animieren. Warum das ein Geben und Nehmen ist, "networking" nützlich sein kann und woran viele Kongresse bei jungen Leuten scheitern, darüber spricht er im Podcast.

Neue Krebstherapien werden für immer kleinere und spezifischere Tumorentitäten zugelassen. Große klinische Zulassungsstudien sind damit nur schwerlich möglich. Auch ethisch wären sie ein Dilemma. Das Problem beklagen Onkologen seit langem. Helfen sollen nun die klinischen Krebsregister. Was die leisten können und was das für Ärzte bedeutet, darüber spricht Denis Nößler mit Helmut Laschet, unserem Korrespondenten beim 34. Deutschen Krebskongress (DKK) in Berlin, in der Episode vom "ÄrzteTag"-Podcast. Und sie reden über die Unterschiede zu epidemiologischen Krebsregistern, und was deren Vorteile sein können. Foto: Bernd von Jutrczenka / dpa

About romantic relationships and equality between sexes. Can one strive for marriage, celebrate Valentine's and still be a feminist? We will look at it in theory, as well as analyze Harry & Meghan’s and Beyoncé & Jay Z’s relationships.  To support this podcast, you can donate as little as 5 DKK per episode at https://notyourrib.10er.app

En fælles global faktor har været altdominerende på valutamarkedet – ikke mindst i Skandinavien – på det seneste: Corona-virus har vist sig som en human katastrofe, men for markederne ser risikoappetitten ud til så småt at stabilisere sig. I norsk økonomi er der fortsat et underliggende omkostningspres, og Norges Bank er i vores optik priset ‘for blødt’, mens en underliggende svaghed i svensk økonomi står til at blive en udfordring for Riksbanken. Vi ser derfor NOK og SEK bevæge sig i hver sin retning mod DKK, hvis/når den globale faktor lægger sig igen. I dag er Jesper Pedersen og Kristoffer Kjær Lomholt gæster hos Christin Tuxen.

En startup er ofte en meget kompleks og kringlet process og derfor dykker vi helt ned og kigger på processen under en loop i dette afsnit. Vi snakker blandt andet interaktionsteknologi, Software Development Kit (SDK) og innovation. Men vigtigst af alt snakker vi iværksætteri: Fra hvordan en ide starter, til Proof of Concept (POC), til prototype, til Minimal Viable Product (MPV), til pitch konkurrencer, oprettelse af CVR nummer, pre-seed funding, VC funding, Business Angel funding…Elias og Frederik er eksempler på unge succesfulde iværksættere på deres første rejse som har oplevet både successer og pitfalls, som på 2 år er gået fra et skoleprojekt til at rejse funding i millionklassen og nu driver en startup med flere ansatte hvor fokus konstant er på vækst.Hvis du har interesse i at lære om iværksætteri helt tæt på og hvordan man kan skabe en succesfuld virksomhed, så kan jeg love dig at der er mange guldkorn at finde i denne samtale.Velkommen til KREATION. 00:20 Velkommen til Elias og Fredrik fra Obital00:50 Pitch: Hvad er Obital?03:01 Roller i en startup06:45 Starten af Obital11:10 At finde et hul i markedet12:00 Market Pull eller Technology Push14:00 Radical Innovation eller Incremental Innovation14:30 Findes der originale ideer?15:30 Hvornår beslutter man at blive fuldtidsiværksætter?20:00 Seeing is believing21:30 Fra ide til prototype til Proof of Concept24:40 Første pitfall: første investering27:20 Hvordan lander man sin første funding? Innovationsfoden’s InnoBooster32:30 Næste step: Marked validering?36:00 Hvad er et pilotprojekt?41:30 Involver brugerne hurtigst muligt43:00 Det handler ikke om ideen men om eksekveringen44:40 At sælge til det offentlige?46:55 Hvad gør man efter sin første funding på 500.000 DKK?49:00 Første ansatte51:30 Hvilke slags investeringer findes der for startups?53:00 Hvilken slags investering skal man vælge?57:00 At lande sin første rigtige investering? (pre-seed)59:00 Tilgå investering som dating01:01:00 At blive en dygtig iværksætter01:04:30 Hvor lang tid tager det at rejse penge?01:07:15 Hvad er en konvertibel note?01:09:00 Vigtigheden af at finde den helt rette første investor01:12:30 Hvordan bruger man tiden mest optimalt som early stage?01:16:00 Man må gerne sige nej til penge!01:21:10 Vær strategisk omkring timing af funding01:23:45 Hvad har gjort Obital til en succesfuld case?01:29:15 Hvornår skal man lancere sin første version af sit produkt?01:33:20 Software Development Kit (SDK) (Unity Modellen)01:34:30 Hvad kan man bruge eye tracking til?01:40:00 Fremtiden for interaktionsteknologi

Mary McGovern interviews translator Anton Jarrod about his first translation of a book by Martinus – “The Christmas Gospel”. It will be published for the first time in English on 10th December. When Martinus gives his lecture on “The Christmas Gospel” on 10th December 1944, the world is still in the darkness of war and largely unaware of its most abhorrent horrors. But its end is approaching and there is a glimmer of light. And it is this light in the darkness that is perhaps the very subject of Martinus's cosmic retelling of the nativity. For him, the gospels reveal and symbolise a fundamental fact about the evolution of cosmic consciousness – that it is born or emerges in the terrestrial human being, living in the darkness of the animal kingdom. The cosmic story of the living being's evolution and the various aspects of life that relate to it are also seen to be told through the nativity narrative. The virgin birth, the persecution by Herod, the gifts of the three holy kings, and the message of peace and good will as told in the gospels reveal as much about the evolution of society, of science and art, of sexual pole transformation and sexual development as they do about the life of Jesus. And it is this hidden, deeper layer of meaning that Martinus presents to his readers in a fascinating little book that is now available in English, from 10th December 2019, exactly 75 years since Martinus gave the lecture that forms the basis of this book, which he published in Contact Letters during 1945-46. During our own troubled times, reading The Christmas Gospel may throw some warm light this winter. 128 pages, price 55 DKK incl. Danish tax, 44 DKK excl. tax (approx. £5, US$6.50. €6 plus postage). Available from shop.martinus.dk from 10th December. Anton Jarrod is a writer and researcher currently living in London and Cambridge, UK. He writes and speaks about modern spirituality. He is also the author of “Martinus Cosmology and Spiritual Evolution” – a book about the work of Martinus, whom he describes as “one of modern spirituality's still undiscovered gems.” http://www.antonjarrod.com/ This podcast was recorded by Mary McGovern in Frederiksberg, Copenhagen, Denmark on 30th September 2019. Music composed and performed by Lars Palerius. Martinus' literature is available online on the Martinus Institute's website: www.martinus.dk Here you can also find information about the international summer courses at the Martinus Centre in Klint, Denmark.  

Why do we put so much value in female virginity, while male virginity has no value whatsoever? When I met my first man, proudly, I told him, that I was a virgin. And only some months into our relationship in a candid conversation, he confided in me, that he was a virgin as well. As a Christian, I praised him for it. But, to my shame,dee p inside, I was disappointed. I was proud of saving my virginity for marriage, but I expected my future husband to be an experienced lover….. To support this podcast, you can donate as little as 5 DKK per episode at https://notyourrib.10er.app

Steinar Þór Ólafsson markaðsstjóri Skeljungs er meðal annars menntaður íþróttakennari og rak Crossfitstöð í Lúxemburg. Í þessu í viðtali segir hann okkur frá þeim áskorunum sem liggja fyrir hjá markaðsstjóra í fyrirtæki einsog Skeljung, sem reka sínar bensínstöðvar undir merkjum Orkunnar. Steinar hefur líka verið mjög duglegur að nýta sér Linkedin, hans mat er að Linkedin sé einn vanmetnasti samfélagsmiðilinn. 
Hann segist vera óhræddur við að setja inn þar það sem honum finnst og að segja sýnar skoðanir.
Mark Ritson barst líka í til en Steinar kláraði nýverið Mini MBA námskeið hjá honum sem hann mælir sérstaklega með. Á Linkedin hjá Steinari segir um hann og Skeljung: Ábyrgð á öllu markaðsstarfi Skeljungs á einstaklings- og fyrirtækjamarkaði á Íslandi sem og hluta af alþjóðlegri sölu félagsins til skipa í N-Atlantshafi. Skeljungur starfrækir 65 bensínstöðvar á Íslandi undir vörumerkinu Orkan. Á fyrirtækjamarkaði selur og dreifir Skeljungur skipaolíu, eldsneyti, efnavöru og áburði til fyrirtækja og einstaklinga í atvinnustarfsemi ásamt því að reka olíuprammann Bark sem þjónustar m.a. olíu til erlendra skemmtiferðaskipa í Reykjavíkurhöfn. Skeljungur er móðurfélag Magn, fyrrum Shell í Færeyjum, með 135 starfsmenn og 690 milljón DKK í árlega veltu. En einnig á Skeljungur þriðjungshlut í WEDO eiganda vefverslunarinnar Heimkaup.is

”Top-1% af Enterprise Software sælgere forbereder sig, har en stærk proces og kan finde ud af at føre en kunde fra A til Z samtidig med, at fjerne de forhindringer, som der måtte være undervejs.”  - Casper Kræfting, Sales Director, Peakon Lyt med til denne episode af AltOmSalg hvor jeg interviewer salgsdirektør af Peakon, om hvad der definerer de dygtigste top-1% af de dygtigste Enterprise Software sælgere, samt hvordan man strukturerer en global enterprise software salgsafdeling. Vi taler teamstruktur, lead-kvalificering, KPI’er, samt relevante salgs frameworks - glæd dig! Peakon er en dansk HR-software virksomhed, som tidligere på året rejste ca. 230 millioner DKK i deres serie B runde. Peakon har udviklet en real-time employee engagement platform og har samlet mere end 51 millioner datapunkter fra kunder og deres ansatte verden over. Få adgang til Peakon's seneste rapport her: www.heartbeat.peakon.com

I denne uges udgave af Valutakrydsild kigger vi mod ECB, som efter alt at dømme vil lancere en pakke med lempelser på september-mødet. Selvom der er stor usikkerhed om, nøjagtig hvad og hvordan ECB vil lempe, skal man dog i vores optik ikke regne med, at meddelelsen i sig selv får den helt store betydning for valutamarkedet. I brede termer er USD på det stærkeste niveau i år, hvilket afspejler, at markedet har store forventninger til ECB – og begrænsede forventninger om amerikanske rentenedsættelser. USD-styrkelsen kommer formentlig før og – i mindre grad – efter, at ECB lemper. DKK, CHF og JPY bliver ligeledes styrket i disse uger på forventning om, at de ikke kan/vil matche rentedyk fra ECB. I studiet er Piet P H Christiansen (gæst, ECB-strateg) og Christin Tuxen (vært, valutastrateg).

I denne uges udgave af Valutakrydsild er centralbankerne det altoverskyggende emne. Fed har allerede klart kommunikeret, at der skal lempes. Og efter en række udmeldinger tidligere på ugen har vi ændret vores kald på ECB og tror nu, at de vil levere en bred vifte af lempelser i sensommeren. Det presser centralbankerne andre steder i Europa, både i Sverige og Schweiz, hvor ikke mindst sidstnævnte nu kan blive presset til at bevise, at man har værktøjskassen og troværdigheden intakt. Vil det lykkes? Det er langt fra sikkert og er samtidig én af grundene til, at vi ser en (lidt) svagere USD og en stærkere CHF mod DKK på den korte bane. I studiet er Christin Tuxen (vært, valutastrateg), Jens Nærvig Pedersen (gæst, valutastrateg), samt Kristoffer Kjær Lomholt (gæst, valutastrateg).

LIVE on the Third World Congress of Sports Physical Therapy Facebook page, I welcome Professor Ewa Roos to discuss the GLA:D Program. Professor Roos is an internationally leading researcher and change agent in the field of musculoskeletal health. She has been able to both produce high-impact clinical research and translate that research into clinical tools that are easily and effectively implemented in hospitals, primary care clinics and even community settings in municipalities. In this episode, we discuss: -The three components that make up the GLA:D program -Are GLA:D exercises superior to performing any other form of exercise? -The benefits of participating in group therapy -A sneak preview into Professor Roo’s talk at the World Congress of Sports Physical Therapy -And so much more!   Resources: 3rd World Congress of Sports Physical Therapy GLA:D Program Ewa Roos   For more information on Professor Roos: Professor Roos has a passion for advancing the frontiers of knowledge in muscle and joint health to improve the quality of life of those with musculoskeletal disease and to improve health care delivery for these conditions. Her focus is on patient involvement, non-surgical and surgical treatments and clinical care pathways. A decade ago Professor Roos and colleagues started to investigate the evidence underpinning the outcomes from arthroscopic knee surgery. When they found very little evidence to support the ever-increasing frequency of these surgical procedures, they started investigation of the efficacy of arthroscopic surgery compared with sham surgery or structured exercises through a series of high quality randomised controlled trials performed in collaboration with Danish and Norwegian orthopaedic surgeons and physiotherapists. To the surprise of many and the concern of some, the results of these and other research projects have found that arthroscopic surgery for the degenerative knee is no better than sham surgery or non-surgical treatments for improving pain and loss of function. Professor Roos is an internationally leading researcher and change agent in the field of musculoskeletal health. She has been able to both produce high-impact clinical research and translate that research into clinical tools that are easily and effectively implemented in hospitals, primary care clinics and even community settings in municipalities. She has also served as an expert on clinical guideline committees for osteoarthritis (Sweden and Norway 2003, Sweden 2012, 2017--, Osteoarthritis Research Society International 2014, China 2017), knee osteoarthritis (Denmark 2012) and meniscus pathology (Denmark 2015), thereby impacting the delivery of clinical care in the Nordic countries and worldwide. One of the principal outcomes from her research has been the development of the Good Life with osteoArthritis in Denmark (GLA:D®) project for people with knee and hip pain. The GLA:D® project is an outstanding example of how to successfully implement evidence-based clinical guidelines in primary health care practice and municipalities. Its underlying principles focus on patient education, patient empowerment, exercises and self-management. Since 2013, more than 1000 clinicians nationwide have been trained in delivering GLA:D® care to about 30,000 patients, who report remarkable improvements in health in terms of less pain, less disability, consumption of less pain medication, increase in physical activity, reduced sick leave and return to work (www.glaid.dk). The GLA:D® project now serves as a template for establishing similar initiatives in other countries including Canada (2015), Australia (2016) and China (2017). Professor Roos’ research unit at University of Southern Denmark now has 20 members, attracting international recognition for its involvement in evidence-based medicine, development of patient-reported outcome measures and pioneering research in the field of joint injury, osteoarthritis and the role of surgery and exercise in treatment. Professor Roos plays an active role in breaking down the barriers between disciplines and forging interdisciplinary teams to collaborate on addressing key research questions of common interest. She is open-minded and inclusive, welcoming the opportunity to work with other disciplines and professional groups - a trait not always found in academia – to ensure the highest standards and the best possible outcomes for people suffering from musculoskeletal disease. To this end, she has been integral to the creation of the new Center for Health in Muscles and Joints at the University of Southern Denmark, which aims to become the leading institution in Denmark for information exchange, interdisciplinary research and innovation in the domain of musculoskeletal health. Professor Roos has published many articles in lay language targeting patients with osteoarthritis, often in collaboration with the Swedish and Danish Rheumatism Associations and she has made hundreds of appearances in printed and electronic media and TV. She takes every opportunity to increase political awareness of the impact of muscle and joint disease for the individual and the society and the proven benefits of physical activity for those with these conditions in Denmark and internationally, to raise its visibility through public debate, and to advocate for its recognition as a public health priority to offer treatment of muscle and joint disease equal to that of other chronic diseases including heart disease and diabetes. In 2014, her contribution to public health was recognised when she won the OARSI (Osteoarthritis Research Society International) Clinical Research Award for her “outstanding work in exercise as prevention and treatment of joint pain, joint injury and osteoarthritis”. This is the first time this highly competitive award was given to someone other than a medical doctor and to a Danish researcher. In addition, in 2014, she was awarded the Queen Ingrid of Denmark’s prize for outstanding arthritis research by Queen Margrethe II of Denmark, and the Danish Rheumatism Association (Gigtforeningen). Professor Roos is the author of 205 peer-reviewed publications. She has published in high impact journals such as the New England Journal of Medicine, the British Medical Journal and The Lancet. Her work has been cited in total 10952 times with 1 paper cited more than 1100 times and 23 additional papers cited more than 100 times. Her h-index is 54 (January 2018). She has supervised 21 PhD theses to completion with her students having professional backgrounds in medicine, physiotherapy, nursing and sports. Four of her PhD students have received awards and/or prestigious post-doctoral funding from the Swedish or Danish Medical Research Councils. Her success in attracting project funding is testament to the value that funders place on her research. In total, she has attained over 27 million SEK, 10 million DKK, 0.6 million AUD, 0.8 million CAD, 0.9 million USD and 4.2 million Euro as applicant or co-applicant since 2005.   Read the full transcript below: Karen Litzy:                   00:00                My name is Karen Litzy. I'm a physio therapist. I'm based in New York City and I am so happy to be on the Third World Congress of Sports Physical Therapy Facebook page interviewing Professor Ewa Roos. And we are going to talk a little bit about her background and the GLA:D program and a sneak peek at what she's going to be speaking about at the Third World Congress, which is October 3rd through the fifth in Vancouver, Canada. So Professor Roos, thank you so much for taking the time out and joining us today on this Facebook live. Ewa Roos:                     00:44                Thank you. It's very exciting to meet you Karen. Karen Litzy:                   00:47                Yes. And for all of you who are on watching, if you have questions, we can see them. So feel free to put questions in as we get a little bit more into the conversation. But before we get to the meat of what our interview is about, can you talk a little bit more about yourself? Ewa Roos:                                             Okay. So what do you want to know? Karen Litzy:                                           Well, let's talk about how long you've been a physio therapist and kind of what led you into the work that you're doing now. Ewa Roos:                     01:16                Okay. So I've been a physiotherapist since I graduated back in 1981. So that's a really long time ago. And the reason why I moved into this area was because I was very much involved in sports. I went to a sports high school and I competed on the national team in my sport, which is something called orienteering when you're running in the forest with the use of a map and a compass. And I got an obvious injury and suddenly I couldn't run as much as I wanted to run. And I visited a number of sports medicine doctors and they actually can’t tell me either and that built up some frustration and eventually actually have surgery for these overuse injuries. That was not very smart either. So that really sparked my interest and then my career. And then getting a degree in physical therapy was the fastest way of getting to work with what I wanted to work with Sports medicine. Karen Litzy:                   02:21                And what took you from that, from getting your degree to where you are now? Professor, researcher. Ewa Roos:                     02:28                When I think back I realized that I had aspirations of becoming a researcher already as a kid. I published my first paper back in the 80s. But it didn't really take off until I found a very good supervisor in the mid nineties and that's good advice, I think. Find yourself a good supervisor. Karen Litzy:                   02:57                And so you’ve been conducting research in that since the 80s. And can you tell everyone where you currently are working? Ewa Roos:                     03:05                So I'm working at University of Southern Denmark. Karen Litzy:                   03:09                And that takes me into the GLA:D program. So before we start talking more about it, can you let the listeners know what does GLA:D stand for? Ewa Roos:                     03:22                So GLA:D stands for good life with osteoarthritis in Denmark. Karen Litzy:                   03:26                And when did this program start? Ewa Roos:                     03:30                So I think I would like to start by saying that while I am a researcher, GLA:D is not really a research because GLA:D came out of the frustration I felt knowing about all the evidence that was out there and sitting on clinical guideline committees in Sweden, Norway, Denmark, China and globally. And we could see that all guideline committees, they're recommended patient education, exercise and weight loss if you were overweight as first line treatment for osteoarthritis. And there were lots of money spent on these clinical guidelines, but nothing changed in clinical practice because of these guidelines. So GLA:D actually came out of pure frustration and we realized that something needs to be done to help clinicians implement these clinical guidelines into their practice. That was the beginning of the GLA:D program and that was in 2013. Karen Litzy:                   04:41                Okay, so it's yourself, Soren Skou. Yes, I pronounced that correctly. Ewa Roos:                     04:48                Soren Skou was my PhD student at that time. And Soren is a very young, smart, energetic young man and the combination of the two of us was really good to make things happen. Karen Litzy:                   05:05                Okay. So before we get into, and we'll talk about some of the discussions on social media regarding the GLA:D program in a little bit, but before we get into that, can you talk a little bit more about what is involved in the program and how it works? Ewa Roos:                     05:23                Okay, so the whole aim is really to improve quality of care for patients with osteoarthritis and to do so we use three components. The first is that we educate clinicians in Denmark, it's mostly physiotherapist. It could basically also be other clinicians who have the sufficient background and knowledge about osteoarthritis and knowledge about exercise as treatment. So we have a two day course to educate about osteoarthritis and about delivery of exercises. That's the first component. The second component is then what these clinicians deliver in the clinical practice. So that is patient education and exercise therapy, which is group based and supervised by a clinician built on evidence. And the third very important component is that we evaluate the outcomes with an electronic registry. But I would again like to point out that this is not per se a research project because this is uncontrolled and this is real life. This is what happens across a nation. Karen Litzy:                   06:46                I think it's important to note that this is not like a randomized controlled trial, you’re collecting the data that you are finding from clinicians, from actual patients sort of in the trenches so to speak. Ewa Roos:                     06:59                Yes. So if you run most controlled trial, everything is very much controlled. That's not the case when you do it in real life clinical practice, but GLA:D it's a minimum, it's a core package of patient education and a 12 exercise sessions. But as a clinician you're always the one who determine what your specific patient need. So you have to deliver the patient education and you have to deliver the exercise, but you are absolutely free to add whatever you think your patient may need. They may need manual therapy to improve the range of motion of the joint or something else. That is absolutely fine. You can also send them to a dietician if you think that would be beneficial for them, et cetera. Karen Litzy:                   07:53                And so sorry for that. We may hear horns and sirens because I'm in New York City, so I apologize everyone. So as far as the program is concerned, so it's not like a clinical practice guideline but rather a full program. So I guess my question is if clinical practice GLA:D guidelines weren't being followed, how do we know that the program is going to be something that's sustainable and followed? Do you know what I mean? Like if therapists were like I'm not following these clinical practice guidelines. Ewa Roos:                     08:31                So, I’m not really sure I understand your question. But, so I think that's probably why to be able to answer that or respond to that question I would say that it's basically that we can see that clinicians want to take the courses and we can see that they actually register patients in the registry and we can evaluate the outcome. And that's a very good way of measuring the quality of what's being delivered. We can see how many sessions they have attended, for example, and things like that. Karen Litzy:                   09:06                Yeah, yeah, exactly. So if I'm a clinician, so if I'm looking at it from the clinician standpoint, for me, it gives me some accountability. Right? So it's like, of course we're always accountable to our patients and should be to ourselves. But it's always good to know that you're being held accountable and being held to a certain standard for your patient in order to kind of be part of the program, if you will. And I think that's important because otherwise, I mean, human beings, right? We get lazy and we're not following things as best as we should. So I think that's an important component of the program. Ewa Roos:                     09:55                I would say that the longer we go on, the greater is the part that has to do with quality assurance. Karen Litzy:                   10:03                Absolutely. Yeah. And so, you know, let's get into some of these discussions on social media now that we have a better idea of what the program is, so some of the discussions are regarding whether the GLA:D program is superior to performing other forms of exercise. But what are your thoughts on this? Ewa Roos:                     10:24                Yeah. Okay. So when you do a research study, the primary outcome can be pain relief. And if you look at randomized control trials and if you look at the effect that you find from different exercise program, there are no studies showing that one type of exercise is superior to another program when it comes to pain relief. So when the neuro muscular exercise program that we used in GLA:D is being compared to other exercise program, we can say it's similarly effective, but it's not more effective than other exercise programs. But what is interesting is that we can see that when we deliver it in clinical practice, one of the thing is that we're able to teach it to physiotherapists with very different backgrounds. You know, we have taught more than thousand physiotherapists in Denmark and some of them are real musculoskeletal experts, but some are not. Ewa Roos:                     11:28                And just being able to teach a program to clinicians with very varying background that is in itself, something that requires a good framework for the program. I think. So that is one aspect and then we can see that we're actually able to have about 25% pain relief directly after program. So we can kind of duplicate the findings that we have in randomized controlled trials. But what I think is even more important is that we can maintain that improvement at one year. And that is something that we don't always see in randomized controlled trials actually. So in some regards it looks like we're doing better than in the randomized controlled trials. And this is not a research project. So I can't tell you why I can just say that the clinical findings are really good and encouraging because it looks like there must be some kind of a better understanding of the disease from the patient's perspective. And there are some indications that there are some lifestyle changes. One third for example, report that they have increased their physical activity level. We can see that one out of three stop taking painkillers and we can see that there is a lot less sick leave, especially among the knee OA patients at one year. Karen Litzy:                   12:58                And do you feel that, at least in Denmark, I'm assuming if a thousand therapists have gotten through this, this is a pretty recognized program in the country. So do you feel like patients have more buy in so to speak because it is a recognized program? Ewa Roos:                     13:17                That's a very interesting question. And my feeling is that there was more buy in from patients, from clinicians and from those referring to the program that is general practitioners and orthopedic surgeons. What the general practitioners tell me is that they really like to refer to program where they know the content of what is being delivered. They don't really like to refer to a physical therapy as a black box treatment that they don't really know what is going to be delivered. And I guess to some extent they may be right because there has been delivered passive treatments for which there is really no evidence in these patients. Karen Litzy:                   14:07                And the other thing that I find interesting about the program is that it's in a group setting. So you have a lot of people together in one group and I also wonder does that also foster, first of all, it's a nice sense of community, you have a support group. Again, accountability on the patients. If it makes them more accountable, they’re doing their exercises, right? And they've got the support. Ewa Roos:                     14:36                Yeah. You can see that when you go and audit the clinics that you can kind of see the interplay between the patients. And there was some kind of positive peer pressure, you know. And for example, we do some exercises on the floor very deliberately and there may be older patients who come in and say, I cannot get down on the floor because I haven't been on the floor for the last 10 years. You know? And the physio can say, well that's fine, you don't have to, you know. But after a few sessions, that person will be on the floor, not with the help of the physio, but inspired by the other patients and as some kind of side effect, you know, they're also learn how to get up with the help of a chair and they get less fear of falling because they know they can get up again. Karen Litzy:                   15:22                Right. And I look at that as such a positive for the program, but also for the patient, the individual patient, because then they're more likely to do the exercises. I’m sure part of it is they're doing exercises on their own. I would assume it's not just twice a week or however many times a week you're coming into the program. Ewa Roos:                     15:44                So what we told them actually is that this is twice a week. And we do not require them to do anything at home if they want to, sure they can do it. But there is no requirement of home exercises. And I think that makes it maybe, but this is pure speculation, a better experience because you feel sure if you're more secure about what you do, you have someone to hold your hand because it's painful to start exercising when you have osteoarthritis and you ask your body to do things you haven't done for a long time. And many people get anxious if they should exercise at home and they also feel bad conscience if they don't do it. So actually I think it seems to be a better experience to tell people do this twice a week. We know it will be better if I did it three times a week. But we also know that for most people it's not possible to squeeze that into their daily life. So it's a very pragmatic decision to say twice a week because that is what most people can do. It's not the best, but it is pragmatic. Karen Litzy:                   16:55                And do you find that your class attendance is always very high? Meaning are there a lot of dropouts? Ewa Roos:                     17:04                Yeah. So if we look at the last annual report that I have access to was from 2017 we are about cleaning of the data for 2018 but that was nearly about 30,000 patients. And we can see that eight out of 10 patients have completed at least 10 supervised sessions. That is very good, I think. Karen Litzy:                   17:27                Very good. Yeah. Because you know, people always say exercises are great, but if you’re not going to do it it’s not going to make any bit of a change. Now is there anything else about the GLA:D program that you'd like to talk about and let everyone know about before we talked more about what you're going to be speaking about at the conference? Ewa Roos:                     17:53                So I think it's important to say that the GLA:D program would not be the success it is if it didn't have the buy in from the clinicians and that the clinicians wouldn't feel that it really supports their clinical practice. And because it's the clinicians who take ownership of the program and it's them who kind of market it in their local areas, it's them who inform the general practitioners. So GLA:D is really more of a grass root movement or bottom up initiative or whatever you would like to call it. We actually had no, or very, very little funding to get this whole thing started. We actually only had funding to set up an electronic registry. That was it. The rest was just pure frustration, hard work and wonderful support by all the clinicians who have embarked on this and they feel that it really eases their daily practice and it has also made it possible for them to attract new patients. So it's actually been a good business for them in that sense. Karen Litzy:                   19:06                Yeah, and I also liked that you mentioned earlier that if you've got a patient taking part in the GLA:D program, that it doesn't mean that you're not perhaps seeing them for one on one therapy as well. Ewa Roos:                     19:19                So GLA:D, it's a framework, you know, and there are some core things that you have to deliver, but if you would like to deliver extra things on that because you are the clinician, you're the only one that knows the patient. I think that's really, really important to stress. And I think this pragmatic approach and this flexible approach is part of the success. And that may come because we have all worked for very long in the clinic and know what it's like to be in the clinic and we know that it needs to work. So for example, if it was a research project, we also do functional tests. Like we look at walking speed and chair stands just for example. And if you did that in a research project, you would do three attempt, you know, but we don't do that. We only do one attempt because that is what you can do in clinical practice. So, we have tried to do everything in a way that we evaluate the outcome. We can check the quality, but we've done it with minimum resources on the therapist. Karen Litzy:                   20:38                And oftentimes that's what it's like when you're in a clinic. Ewa Roos:                     20:41                You need to make your ends meet during the daily work because else you won't do it. Karen Litzy:                   20:51                Exactly. Exactly. And I think it's also worth mentioning that the GLA:D program is not only in Denmark, it's also in let me see if I can remember Australia, China, Canada. Ewa Roos:                     21:07                Yes. This year in April, Switzerland will come on board. In November in New Zealand will come on board. Karen Litzy:                   21:16                Great. And the thing that I found really interesting is in China is that it's physicians who are running the program, their orthopedic surgeons, which is in your head, you think, well, that was interesting. It's competition, so to speak. But I think it's, I think that's great. And hopefully in other countries, hopefully you guys will expand in other countries in the near future as well. All right, so let's get to what you're going to be speaking about at the Third World Congress of sport physical therapy. So can you give us a little preview? Ewa Roos:                     21:55                Okay. So we haven't been talking much about research. We've been talking about implementing clinical guidelines in clinical practice. But I think I have been so fortunate that I actually grew up academic department of Orthopedics and that has put me in a position that I've had many close collaborations with orthopedic surgeons and we have across professions then been interested in surgery and exercise therapy as treatment for different kinds of problems, mostly knee problems. So, over the years I have been involved in randomized controlled trials where we have compared surgery to exercise for an acute ACL tear in the young active populations, for a meniscal tear in the middle aged population and for severe osteoarthritis in people that we have provided with nonsurgical treatment, comprehensive package and then randomized them to have a total knee replacement in addition or not. So I will talk about the outcomes of these trials and I will talk about how you as a clinician can use these results in a shared decision making with your patients. Karen Litzy:                   23:20                And I think that's so important, having that shared decision making, being honest with your patients and giving them all points of view so that they can then make the decision that’s best for them. Ewa Roos:                     23:31                Yes, because there are pros and cons with different treatment strategies and there is not one treatment strategy that fits all patients, but I think it's really good if patients can get informed so they're able to make a treatment decision that is right for them. Karen Litzy:                   23:52                Well I am definitely looking forward to that and you know, as we speak, I am seeing and a 12 year old girl who had an ACL tear with subsequent surgery, and I see a lot of ACL patients. So that is something that I always try and give, you know, all views so that they can make the best decision. And sometimes that involves being the quote unquote bad guy. Ewa Roos:                                             What do you mean by bad guy? Karen Litzy:                                           Well, not bad guy, but sometimes telling them things that they don't want to hear saying to the patient because you're trying to give them all points of view and sometimes patients don't want to see all points of view. I think oftentimes, and this has been my experience with patients is they want to hear the point of view that is going to confirm what they've already decided without hearing all the points of view Ewa Roos:                                             Confirmation bias. Karen Litzy:                                           Right. And so sometimes you have to if you want to be open and honest with your patient and give them all of the information that they can take with them to make that decision. Sometimes you have to tell them things that maybe they're not wanting to accept. Ewa Roos:                     25:15                It would be very beneficial if we could develop educational packages or educational tools for young patients as well. Just as we have for osteoarthritis patients. That will be really beneficial. But it's a hard nut to crack because when you're young, you think you're invincible and your perspective is not very long. You want things to happen here now or yesterday would have been even better. Karen Litzy:                   25:43                Well, I'm definitely looking forward to that because I'm always looking for better ways to communicate with my patients and really to be able to give them all of the information they need. So I am definitely looking forward to your talk.  And we've got a couple of comments that I'll just read. All right. I am going to not say this person's name right, but Meredith Gosh, I hope I said that correctly. She said, your work is incredible. Your work is incredible. You truly make the world a better place. So proud to know you. Hope to see you soon. Karen Litzy:                   26:47                And then another one from Jay F Esqulare who is part of the world Congress, said you're a pioneer in the world of physio therapy, knee injuries, osteoarthritis and rehab programs such as GLA:D, so amazing to have you at SPC 2019. So, hopefully, everyone who is listening will now be a little bit more curious. Will want to come to Vancouver to listen to your great talk. So again, it's Vancouver October 3rd through the fifth of this year, 2019 in Vancouver. All the information is right here on the Facebook page. So you can go and click on the link on the Facebook page and we'll even put it underneath this video. And if it's okay with Professor Roos, we can also maybe put some links to the GLA:D program as well. Ewa Roos:                     27:50                You can link to GLA:D Canada and GLA:D Australia and you will find information in English. That might also be a good thing. Karen Litzy:                   27:57                Awesome. Yeah, that would probably be great, we're going to be in Canada even better. So in English. Ewa Roos:                     28:03                If you link to GLA:D Switzerland, you will also get information in French, German, and Italian. Karen Litzy:                   28:10                Awesome. So we've got a lot of languages covered there which is wonderful. So Professor Roos thank you so much for taking the time out of your day today and coming on, and I look forward to seeing you in Vancouver in a couple of months. Ewa Roos:                     28:24                Nice talking to you Karen. Karen Litzy:                   28:27                Thanks so much. Bye everybody. Thanks so much for coming on and we'll see you in a couple of weeks with another interview.   Thanks for listening and subscribing to the podcast! Make sure to connect with me on twitter, instagram  and facebook to stay updated on all of the latest!  Show your support for the show by leaving a rating and review on iTunes!

In our weekly podcast, Macro Strategy Views, we discuss the similarities and differences between the Scandinavian countries and the eurozone in terms of the outlook for interest rates. Global Head of FI&C Research Thomas Harr chairs today’s podcast and he is joined by our Chief Economist in Denmark Las Olsen, our DKK strategist Jens Nærvig Pedersen and our Scandi strategist Kristoffer Kjær Lomholt. Demographics, higher inflation and better trend growth suggest that Norwegian rates will be above eurozone rates. The Riksbank will be constrained by the ECB, in contrast with Norges Bank. However, favourable demographics, higher trend growth and falling savings imply that Swedish rates should be slightly higher than eurozone rates. The sharp increase in Danish pension savings is set to continue depressing Danish interest rates.

Christopher Robin Omdahl er youtuber, journalist, spillskaper, podcaster og bassist. Han driver youtubekanalen Retrospill, Podkasten Spillemenn og spiller bass i bandet Blomst. Chris er en god gammel venn av DKK og dette er hans andre runde som gjest på podcasten.

I denne uges udgave af ‘Valutakrydsild’ sætter vi fokus på handelsforhandlingerne mellem Kina og USA. Selvom vi stadig tror på en aftale, er den i vores optik ikke lige på trapperne, men vi har allerede fået en indikation af, hvad implikationerne kan blive i valutamarkedet: Stærkere råvarevalutaer og – på sigt – en svagere USD set i et EUR- og DKK-perspektiv. Og så giver vi – endnu engang – GBP og Brexit et par ord med på vejen. I studiet er Christin Tuxen (vært, chefanalytiker) og Jens Nærvig Pedersen (gæst, senioranalytiker). Denne podcast er alene til orientering. Den udgør ikke et tilbud om eller en opfordring til at købe eller sælge finansielle instrumenter. Danske Bank A/S påtager sig ikke noget ansvar for tab, uanset hvordan dette måtte opstå, ved brug af indholdet af denne podcast. Denne podcast er udelukkende egnet for professionelle investorer og er således ikke egnet for detailinvestorer. Den er heller ikke målrettet personer uden for det Europæiske Økonomiske Samarbejdsområde (EØS). Podcast’en må ikke gengives eller distribueres uden forudgående samtykke. Vi henviser til Danske Bank A/S’ fulde disclaimer, som kan findes på www.research.danskebank.com.

De fleste slår dræbersnegle ihjel,mens andre laver DNA-test og forsker i dem. Ja, sådan er vi så forskellige - heldigvis :)Du lytter til Dyrk og Spis - en grøn podcast og blog, om livet i køkkenhaven. Mit navn er Anders Guldberg og nu skal du med til Århus, hvor Stine Slotsbo bor. Stine har nemlig skrevet en afsindig spændende phD afhandling om dræbersnegle!Så lyt med og få svaret på:- Hvad svensken har med dræbersnegle at gøre?- Hvorfor dræbersnegle er så afsindsyge snedige- Hvad en en god dansk vinterkulde kan gøre for dræbersnegle bestanden? Og ja, tror du at dræbersneglen stammer fra spanien, så tro om igen!Lad os skrue ned for intro melodien og komme til Århus.....Links https://www.facebook.com/DyrkogSpis http://www.dyrkogspis.dk/draebersnegle/ Blogindlæg: Dræbersnegle og andre udyr i køkkenhaven (Den store guide til at undgå dem) http://scitech.au.dk/roemer/feb-13/draebersneglen-klarer-kulden/ Artikel om Stines Slotsbos phD afhandling///Dyrk og Spis er produceret af KhAg - Podcast Made ByØnskes sponsorsamarbejde kontakt anders@KhAg.dkKæmpe tak til Maria Lorentsen for at hjælpe med optagelserne og klipning af interviewet

Her i andet afsnit af vores ugentlige opdatering, får du 3 gode råd fra Martin Thorborg som han ville ønske han havde fået, inden han blev iværksætter. Derudover interviewer Niels to af dem der har deres virksomheder til salg på Saxis. Den ene en super søgemaskineoptimeret webshop, den anden er en App hvor cirkulær økonomi er omdrejningspunktet. Til sidst får du et interview med Trendday, som fortæller mere om hvordan de har brugt de sociale medier til, at skabe en stor webshop på forholdsvis kort tid. Relevante links: Smykke-webshop med organisk omsætning: Udbudspris: 350.000 DKK https://www.saxis.dk/saelges/it-teknologi/internethandel-detail-b2c/smykke-webshop-med-aarlig-organisk-omsaetning-paa-200-000-organisk-78-191-100-til-salg-28960 App til 300K med forretningsplan og samarbejdsaftaler - internationalt potentiale: Udbudspris: 125.000 DKK https://www.saxis.dk/saelges/service/anden-service/app-til-300k-med-forretningsplan-og-samarbejdsaftaler-internationalt-potentiale-til-salg-29016 Se video interviewet med Trendday: https://www.facebook.com/virksomhedsbors/videos/1409047065860143/ Se videoen med Martin Thorborgs 3 råd: https://www.facebook.com/virksomhedsbors/videos/vl.812107012325527/1441531709278345/ —————————— Saxis.dk er Danmarks største online virksomhedsbørs På Saxis.dk kan du oprette en salgsannonce og sætte din virksomhed til salg, eller du kan oprette en bruger og kontakte de forskellige sælgere der er på markedsplafsen. Saxis kan hjælpe både købere og sælgere af virksomheder hele vejen igennem processen. Vi kan hjælpe med Finansiering, juridiske dokumenter, værdiansættelse og rådgivning. Skal du bruge en virksomhedsmægler? - Saxis hjælper dig med at finde den rette Skal du bruge en værdiansættelse? - Saxis leverer en grundig rapport til en god pris Har du spørgsmål eller brug for vejledning sidder vi klar på: Tlf. 33 60 29 29 Mail. info@saxis.dk Find også Saxis her: Facebook: www.facebook.com/virksomhedsbors Twitter: twitter.com/Virksomhedsbors Instagram: www.instagram.com/saxis.dk/ Web: www.saxis.dk

I det 27. afsnit af #pengemedper har jeg besøg af den administrerende direktør for Nasdaq OMX, Nikolaj Kosakewitsch. Vi kommer på lidt under 40 minutter rundt om: • Hvordan de danske aktier er avanceret fra at være skandinavisk lillebror til en sølvplads på størrelsespodiet i Norden • Hvorfor Nasdaq synes, at 5 danske børsnoteringer er tilfredsstillende i 2017 • At den samlede markedsværdi af de danske aktier er gået fra 1300 mia. DKK i 2012 og op til tæt på 3000 mia. i 2017 • At tillid, troværdighed, sikkerhed, teknologi og niche-mæssige verdensklasse-kompetencer er noget af det som udenlandske investorer tiltrækkes af i Danmark, således at hovedparten af de danske aktier i dag sidder på udenlandske hænder • At vi stadig halter bagefter Sverige, når det handler om at aktiekultur • At danske iværksættere hyldes for at sælge, men ikke for at starte og udvikle virksomheder • At overgangen fra C20 til C25 er et tegn på succes • At vi i Danmark de seneste 5 år er gået fra 24 til 42 large cap selskaber • At aktiesparekontoen blev for lille.

Læs mere om virksomheden og kontakt sælger her: https://www.saxis.dk/saelges/service/... Annoncens ID: 29016 Udsnit af salgsannoncen på Saxis: Appen der sælges er til fremme af cirkulær økonomi. Hidtil har den været non-profit, da der har været fokus på at få brugere på. Det er selskabet, der ejer appen m.m. Selskabet er p.t. registreret med en selskabskapital på DKK 50.000. For de DKK 120.000 får du 100% ejerskab over ApS'et (med registreret kapital) og appen m.m. som angivet nedenfor. Om appen: - Investeret DKK 300.000 på udvikling - Findes på engelsk og dansk - Virker i hele verden - Kodet i i PHP + Azure og kodet op til REST API. - Native iOS- og Android - Der er nogle små fejl i appen p.t. —————————— Saxis.dk er Danmarks største online virksomhedsbørs På Saxis.dk kan du oprette en salgsannonce og sætte din virksomhed til salg, eller du kan oprette en bruger og kontakte de forskellige sælgere der er på markedsplafsen. Saxis kan hjælpe både købere og sælgere af virksomheder hele vejen igennem processen. Vi kan hjælpe med Finansiering, juridiske dokumenter, værdiansættelse og rådgivning. Skal du bruge en virksomhedsmægler? - Saxis hjælper dig med at finde den rette Skal du bruge en værdiansættelse? - Saxis leverer en grundig rapport til en god pris Har du spørgsmål eller brug for vejledning sidder vi klar på: Tlf. 33 60 29 29 Mail. info@saxis.dk Find også Saxis her: Facebook: https://www.facebook.com/virksomhedsbors Twitter: https://twitter.com/Virksomhedsbors Instagram: https://www.instagram.com/saxis.dk/ YouTube: https://www.youtube.com/channel/UCfqJaj_CR9m_cKctTLszulQ Web: https://www.saxis.dk/

A key part of many Danish workplaces is their unusual approach to lunch. While many larger workplaces offer Canteens smaller companies also often offer catered lunch. This is done through interesting lunch services that allow you to pay one fee and then pick and choose between 30 or 40 different restaurants at will. While some work places charge on a per-meal basis, the vast majority of Danish workplaces offer a subsidized lunch that usually costs about 360 DKK/month ($60 USD). It's worth noting that these are salary dollars and not post-tax dollars making the value an even better deal. The interesting side effect of this is that Denmark has historically had a very limited lunch restaurant culture. With many workers eating at work and students working at school, the demand for lunch venues you'd find in the UK, US, and elsewhere hasn't existed. There has, also, been a long-standing tradition of Danes taking their lunch to work, which further added to this. While there has been a surge in lunch restaurants over the last 10 years, it is a relatively new aspect of Danish culture. I delve into the topic in this episode of Denmark 101. If you're Danish hopefully you'll find this series interesting, a bit informative, and not too outlandishly offensive. If you're a foreigner coming to Denmark, I hope this helps you build upon observations and insights the rest of us had to find out the hard way. Topics that will be covered include the Danish approach to nudity, how to make Danish friends, how to meet Danes, Danish manners, and even a look at Janteloven. Stay tuned for future updates - this is just the beginning! Explore the stories behind this podcast at http://virtualwayfarer.com. Where you can find me: BLOG - http://www.virtualwayfarer.com FACEBOOK- http://www.facebook.com/virtualwayfarer INSTAGRAM - http://instagram.com/virtualwayfarer TWITTER - http://twitter.com/AlexBerger

This is a small intro to what an IVS is and what you need to start an IVS. An IVS is a limited liability company that you can register in Denmark, with a very low capital requirement of only 1 DKK (less than 1 EUR).

Vi tager igen den almindelige investors briller på, og du får denne gang et indblik i, hvad en investering i Fingerprint Cards (FPC) indebærer. Der er næppe et andet selskab i Norden, der har delt investeringsvandene de seneste år, som FPC har. Aktien er tidoblet – det samme er omsætningen. FPC er en meget betydelig aktør inden for biometri, der handler om identificering af personer ved hjælp af unikke biologiske kendetegn hos personerne. Markedsværdien af FPC er mere end 25 mia. SEK – eller ca. 9 x den forventede omsætning for 2015. Nordnets danske kunder har investeret ca. 800 mio. DKK i FPC (primært kursstigninger), og FPC er den udenlandske aktie, der værdimæssigt fylder mest i depoterne lige nu. (Udgivet den 12. november 2015)

Mesenchymale Stammzellen (MSC) stellen aufgrund ihres Differenzierungspotentials einen großen Hoffnungsträger in der regenerativen Medizin dar. Entsprechend zahlreicher zell- und tierexperi-menteller Untersuchungen scheint die klinische Anwendung dieser adulten Stammzellpopulation im Rahmen einer Zelltherapie in greifbare Nähe zu rücken, wobei MSC als Basis für einen Patien-ten-spezifischen Zell- und Gewebeersatz dienen könnten. In welcher Weise die regenerative Kapazität der MSC durch spezielle Signaltransduktionsmechanismen gesteuert wird, ist jedoch noch weitgehend unbekannt. Vor diesem Hintergrund wurde in der hier vorliegenden Arbeit der Wnt/β-Catenin-Signaltrans-duktionsweg sowohl in humanen (hMSC) als auch in murinen (mMSC) mesenchymalen Stamm-zellen untersucht. Diesem komparativen Ansatz lag das Ziel zugrunde, Gemeinsamkeiten und Unterschiede in diesen beiden Zellentitäten zu evaluieren, um damit langfristig den Grundstein für die Übertragbarkeit von Daten aus nachfolgend geplanten murinen in vivo-Modellen auf die klinische Situation legen zu können. Hierzu wurden zunächst die Basis-Komponenten des Wnt/β-Catenin-Signalweges vergleichend analysiert. Eine Aktivierung des Wnt-Signalweges wurde über Stimulation mit Wnt3a bzw. LiCl in beiden Zellspezies sowie in einem RNA-Interferenz (RNAi)-basierten Ansatz durch Knockdown der für den β-Catenin-Abbaukomplex essentiellen Proteine APC und Axin2 in hMSC erreicht, während eine Inhibtion durch die Transfektion von small interfering RNAs (siRNAs) gegen das transkrip-tionsaktivierende Protein β-Catenin bzw. den Wnt-Korezeptor LRP5 induziert wurde. Dabei zeigten sich neben zahlreichen Gemeinsamkeiten unter anderem hinsichtlich der Proliferation auch klare Unterschiede zwischen hMSC und mMSC. Dies betraf insbesondere die Steuerung von Matrix-Metalloproteinase (MMP)-mediierten Invasionsprozessen, die im Falle von hMSC eine deutliche Wnt-Abhängigkeit aufwiesen, während die Invasionsfähigkeit von mMSC nicht durch den Wnt-Signalweg reguliert wurde. Diese Unterschiede in den zellulären Phänotypen spiegelten sich vorwiegend in einer Spezies-divergenten Regulation der Matrix-Metalloproteinase MT1-MMP wider, da nur in hMSC die Aktivierung der Wnt-Signaltransduktionskaskade mit einer vermehrten MT1-MMP-Expression einherging. Darüber hinaus konnte das Tcf/Lef-Reporter-System in mMSC etabliert werden, das die Quanti-fizierung β-Catenin-abhängiger Expression ermöglicht. Dies erfolgt mit Hilfe eines Reporter-proteins, dessen Expression nur nach Translokation von β-Catenin in den Zellkern induziert wird. Mit diesem System konnte unter anderem auch der Nachweis der funktionellen Plasmid-kodierten Wnt3a-Expression erbracht werden. Derartig generierte Reporter-mMSC könnten vor allen Dingen hinsichtlich einer Anwendung im in vivo-Mausmodell von großem Vorteil sein, da Wnt-aktive MSC mittels eines in vivo-Imaging-Systems visualisiert werden können, um ihre Rolle bei Geweberegenerationsprozessen aufzuklären. In einem weiteren Teilprojekt wurde die Wirkung von Dkk-1, einem Inhibitor des kanonischen Wnt-Signalweges, in hMSC eingehend untersucht. Dabei stand die Analyse der Wechselwirkungen zwischen Dkk-1 und seinem Rezeptor LRP6 im Vordergrund. Versuche zum LRP6-Knockdown brachten ein komplexes Regulationssystem zutage, das eine feinjustierte Balance zwischen akti-vierenden und inhibierenden Signalen impliziert. Die Ergebnisse zusätzlicher RNAi-basierter Experimente wiesen außerdem auf eine funktionelle Divergenz von LRP5 und LRP6 hin. So vermittelt der Wnt-Korezeptor LRP5 vornehmlich aktivierende Signale, wie sie z.B. durch Wnt3a ausgelöst werden, während LRP6 hauptsächlich eine repressive Funktion beispielsweise durch Bindung von Dkk-1 zuzuordnen ist. Da neben den LRP-Rezeptoren auch Frizzled-Rezeptoren (Fzd) eine wesentliche Rolle bei der Wnt-Signalerfassung spielen, wurde zunächst das Fzd-Expressionsprofil in hMSC und mMSC mittels semiquantitativer RT-PCR-Analysen näher untersucht. Dabei zeigte sich, dass alle bisher bekannten 10 Fzds auch in MSC exprimiert werden, dieses jedoch in unterschiedlichem Ausmaß. Zudem ergaben Wnt3a-Stimulationsexperimente in hMSC, dass die Expression von Fzd8 negativ durch Wnt3a beeinflusst wird. Um die Bedeutung von Fzd8 näher zu evaluieren, wurden daher Fzd8-Knockdown-Experimente durchgeführt. Diese ließen erkennen, dass die hMSC-Proliferation maß-geblich von der Fzd8-Expression abhängt, wobei allerdings Fzd8 keinen direkten Rezeptor für Wnt3a darstellt. Zusammenfassend spiegeln die in der vorliegenden Promotionsarbeit erhobenen Daten zum Teil eindeutige Unterschiede zwischen basalen Wnt-regulierten Prozessen in hMSC und mMSC wider, denen insbesondere bei der präklinischen Validierung von therapeutischen Strategien in Maus-modellen eine tragende Rolle zukommt. Da der Wnt/β-Catenin-Signalweg maßgeblich an der Steuerung des invasiven Verhaltens von hMSC beteiligt ist, wie dies in ähnlicher Weise von anderen Forschergruppen auch für die Metastasierung von Tumorzellen nachgewiesen werden konnte, erscheint es zukünftig von vorrangigem Interesse, die hier erhobenen in vitro-Daten in einem in vivo-Mausmodell zu evaluieren. In diesem Kontext kann allerdings nur durch einen komparativen Ansatz, wie er dieser Arbeit zugrunde liegt, die Basis für ein Spezies-relevantes drug design bezüglich des Wnt-Signalweges entwickelt werden, um schließlich aussagekräftige Stamm-zelltherapien bzw. Anti-Tumorstrategien entwickeln zu können.